KR20180050411A - 올리고핵산 변이체 라이브러리 및 그의 합성 - Google Patents
올리고핵산 변이체 라이브러리 및 그의 합성 Download PDFInfo
- Publication number
- KR20180050411A KR20180050411A KR1020187010998A KR20187010998A KR20180050411A KR 20180050411 A KR20180050411 A KR 20180050411A KR 1020187010998 A KR1020187010998 A KR 1020187010998A KR 20187010998 A KR20187010998 A KR 20187010998A KR 20180050411 A KR20180050411 A KR 20180050411A
- Authority
- KR
- South Korea
- Prior art keywords
- variant
- library
- sequence
- oligonucleotide
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108091034117 Oligonucleotide Proteins 0.000 title claims abstract description 283
- 238000003786 synthesis reaction Methods 0.000 title description 50
- 230000015572 biosynthetic process Effects 0.000 title description 49
- 239000002253 acid Substances 0.000 claims abstract description 221
- 238000000034 method Methods 0.000 claims abstract description 156
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 139
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 118
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 60
- 230000000694 effects Effects 0.000 claims abstract description 27
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 23
- 201000010099 disease Diseases 0.000 claims abstract description 18
- 230000003247 decreasing effect Effects 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 127
- 150000007513 acids Chemical class 0.000 claims description 125
- 108020004705 Codon Proteins 0.000 claims description 123
- 102000039446 nucleic acids Human genes 0.000 claims description 116
- 108020004707 nucleic acids Proteins 0.000 claims description 116
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 79
- 230000014509 gene expression Effects 0.000 claims description 37
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 28
- 239000012634 fragment Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 230000002503 metabolic effect Effects 0.000 claims description 18
- 230000002194 synthesizing effect Effects 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 230000001413 cellular effect Effects 0.000 claims description 11
- 238000013508 migration Methods 0.000 claims description 11
- 230000005012 migration Effects 0.000 claims description 10
- 150000003254 radicals Chemical class 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 8
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 230000005754 cellular signaling Effects 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 7
- 241000288906 Primates Species 0.000 claims description 6
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 6
- 230000012010 growth Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 230000003612 virological effect Effects 0.000 claims description 6
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 230000034994 death Effects 0.000 claims description 5
- 208000035475 disorder Diseases 0.000 claims description 5
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 5
- 230000001850 reproductive effect Effects 0.000 claims description 4
- 108091027967 Small hairpin RNA Proteins 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 108020004999 messenger RNA Proteins 0.000 claims description 3
- 108091070501 miRNA Proteins 0.000 claims description 3
- 239000002679 microRNA Substances 0.000 claims description 3
- 230000002062 proliferating effect Effects 0.000 claims description 3
- 230000009758 senescence Effects 0.000 claims description 3
- 239000004055 small Interfering RNA Substances 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 230000002939 deleterious effect Effects 0.000 claims description 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 37
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 23
- 238000012545 processing Methods 0.000 abstract description 16
- 230000035772 mutation Effects 0.000 abstract description 12
- 238000013461 design Methods 0.000 abstract description 7
- 230000009467 reduction Effects 0.000 abstract description 4
- 238000013519 translation Methods 0.000 abstract description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 238000013518 transcription Methods 0.000 abstract description 2
- 230000035897 transcription Effects 0.000 abstract description 2
- 230000008827 biological function Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 description 70
- 235000018102 proteins Nutrition 0.000 description 40
- 238000002515 oligonucleotide synthesis Methods 0.000 description 39
- 206010057190 Respiratory tract infections Diseases 0.000 description 37
- 229940024606 amino acid Drugs 0.000 description 36
- 235000001014 amino acid Nutrition 0.000 description 36
- 239000000047 product Substances 0.000 description 36
- 238000003752 polymerase chain reaction Methods 0.000 description 35
- 230000008569 process Effects 0.000 description 31
- -1 polypropylene Polymers 0.000 description 26
- 239000000758 substrate Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000003153 chemical reaction reagent Substances 0.000 description 24
- 239000000463 material Substances 0.000 description 23
- 239000013604 expression vector Substances 0.000 description 22
- 230000008878 coupling Effects 0.000 description 17
- 238000010168 coupling process Methods 0.000 description 17
- 238000005859 coupling reaction Methods 0.000 description 17
- 239000002773 nucleotide Substances 0.000 description 17
- 125000003729 nucleotide group Chemical group 0.000 description 17
- 230000003647 oxidation Effects 0.000 description 17
- 238000007254 oxidation reaction Methods 0.000 description 17
- 150000008300 phosphoramidites Chemical class 0.000 description 17
- 239000002777 nucleoside Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000003321 amplification Effects 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 238000003199 nucleic acid amplification method Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 11
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 10
- 230000037361 pathway Effects 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 9
- 238000000151 deposition Methods 0.000 description 9
- 102000004196 processed proteins & peptides Human genes 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000002703 mutagenesis Methods 0.000 description 8
- 231100000350 mutagenesis Toxicity 0.000 description 8
- 108010021466 Mutant Proteins Proteins 0.000 description 7
- 102000008300 Mutant Proteins Human genes 0.000 description 7
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000004891 communication Methods 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 229910000077 silane Inorganic materials 0.000 description 7
- 229910052710 silicon Inorganic materials 0.000 description 7
- 239000010703 silicon Substances 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 6
- 108091006054 His-tagged proteins Proteins 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 239000012190 activator Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- WZGZDOXCDLLTHE-SYWGBEHUSA-N Ala-Trp-Ile Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 WZGZDOXCDLLTHE-SYWGBEHUSA-N 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 229940035893 uracil Drugs 0.000 description 5
- QKDAMFXBOUOVMF-UHFFFAOYSA-N 4-hydroxy-n-(3-triethoxysilylpropyl)butanamide Chemical compound CCO[Si](OCC)(OCC)CCCNC(=O)CCCO QKDAMFXBOUOVMF-UHFFFAOYSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000013500 data storage Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- 238000007858 polymerase cycling assembly Methods 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- AVXLXFZNRNUCRP-UHFFFAOYSA-N trichloro(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl)silane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[Si](Cl)(Cl)Cl AVXLXFZNRNUCRP-UHFFFAOYSA-N 0.000 description 4
- 229910052720 vanadium Inorganic materials 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JGAMUXDWYSXYLM-SRVKXCTJSA-N Lys-Arg-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O JGAMUXDWYSXYLM-SRVKXCTJSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000021186 dishes Nutrition 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 238000000059 patterning Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- QTRSWYWKHYAKEO-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-henicosafluorodecyl-tris(1,1,2,2,2-pentafluoroethoxy)silane Chemical compound FC(F)(F)C(F)(F)O[Si](OC(F)(F)C(F)(F)F)(OC(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F QTRSWYWKHYAKEO-UHFFFAOYSA-N 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 2
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- MZRBYBIQTIKERR-GUBZILKMSA-N Arg-Glu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MZRBYBIQTIKERR-GUBZILKMSA-N 0.000 description 2
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 206010053487 Exposure to toxic agent Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091005461 Nucleic proteins Chemical group 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000002318 adhesion promoter Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- IJYZBNLEGDTEBQ-UHFFFAOYSA-N chloro-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl)-bis(trifluoromethyl)silane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[Si](Cl)(C(F)(F)F)C(F)(F)F IJYZBNLEGDTEBQ-UHFFFAOYSA-N 0.000 description 2
- 238000007265 chloromethylation reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- BAAAEEDPKUHLID-UHFFFAOYSA-N decyl(triethoxy)silane Chemical compound CCCCCCCCCC[Si](OCC)(OCC)OCC BAAAEEDPKUHLID-UHFFFAOYSA-N 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 238000001823 molecular biology technique Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002966 oligonucleotide array Methods 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000001020 plasma etching Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 230000033458 reproduction Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000005486 sulfidation Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 150000003628 tricarboxylic acids Chemical class 0.000 description 2
- PYJJCSYBSYXGQQ-UHFFFAOYSA-N trichloro(octadecyl)silane Chemical compound CCCCCCCCCCCCCCCCCC[Si](Cl)(Cl)Cl PYJJCSYBSYXGQQ-UHFFFAOYSA-N 0.000 description 2
- BPSIOYPQMFLKFR-UHFFFAOYSA-N trimethoxy-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CO[Si](OC)(OC)CCCOCC1CO1 BPSIOYPQMFLKFR-UHFFFAOYSA-N 0.000 description 2
- 239000003656 tris buffered saline Substances 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- JFOWDKWFHZIMTR-RUCXOUQFSA-N (2s)-2-aminopentanedioic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(O)=O JFOWDKWFHZIMTR-RUCXOUQFSA-N 0.000 description 1
- GBBJBUGPGFNISJ-YDQXZVTASA-N (4as,7r,8as)-9,9-dimethyltetrahydro-4h-4a,7-methanobenzo[c][1,2]oxazireno[2,3-b]isothiazole 3,3-dioxide Chemical compound C1S(=O)(=O)N2O[C@@]32C[C@@H]2C(C)(C)[C@]13CC2 GBBJBUGPGFNISJ-YDQXZVTASA-N 0.000 description 1
- DXODQEHVNYHGGW-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctyl-tris(trifluoromethoxy)silane Chemical compound FC(F)(F)O[Si](OC(F)(F)F)(OC(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F DXODQEHVNYHGGW-UHFFFAOYSA-N 0.000 description 1
- JUDOLRSMWHVKGX-UHFFFAOYSA-N 1,1-dioxo-1$l^{6},2-benzodithiol-3-one Chemical compound C1=CC=C2C(=O)SS(=O)(=O)C2=C1 JUDOLRSMWHVKGX-UHFFFAOYSA-N 0.000 description 1
- TWQVZFCNOMQQQV-UHFFFAOYSA-N 1,2,4-dithiazole-3-thione Chemical compound S=C1N=CSS1 TWQVZFCNOMQQQV-UHFFFAOYSA-N 0.000 description 1
- WUHZCNHGBOHDKN-UHFFFAOYSA-N 11-triethoxysilylundecyl acetate Chemical compound CCO[Si](OCC)(OCC)CCCCCCCCCCCOC(C)=O WUHZCNHGBOHDKN-UHFFFAOYSA-N 0.000 description 1
- GVZJRBAUSGYWJI-UHFFFAOYSA-N 2,5-bis(3-dodecylthiophen-2-yl)thiophene Chemical compound C1=CSC(C=2SC(=CC=2)C2=C(C=CS2)CCCCCCCCCCCC)=C1CCCCCCCCCCCC GVZJRBAUSGYWJI-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- UUXHICUVBOTXQS-UHFFFAOYSA-N 2-hydroxybutanamide Chemical compound CCC(O)C(N)=O UUXHICUVBOTXQS-UHFFFAOYSA-N 0.000 description 1
- FOYWCEUVVIHJKD-UHFFFAOYSA-N 2-methyl-5-(1h-pyrazol-5-yl)pyridine Chemical compound C1=NC(C)=CC=C1C1=CC=NN1 FOYWCEUVVIHJKD-UHFFFAOYSA-N 0.000 description 1
- IKYAJDOSWUATPI-UHFFFAOYSA-N 3-[dimethoxy(methyl)silyl]propane-1-thiol Chemical compound CO[Si](C)(OC)CCCS IKYAJDOSWUATPI-UHFFFAOYSA-N 0.000 description 1
- GLISOBUNKGBQCL-UHFFFAOYSA-N 3-[ethoxy(dimethyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(C)CCCN GLISOBUNKGBQCL-UHFFFAOYSA-N 0.000 description 1
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 1
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108090000963 Actin-related protein 2 Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UFBFGSQYSA-N Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UFBFGSQYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 108091007065 BIRCs Proteins 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 108030001720 Bontoxilysin Proteins 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102000004018 Caspase 6 Human genes 0.000 description 1
- 108090000425 Caspase 6 Proteins 0.000 description 1
- 102000004068 Caspase-10 Human genes 0.000 description 1
- 108090000572 Caspase-10 Proteins 0.000 description 1
- 102100029855 Caspase-3 Human genes 0.000 description 1
- 102100026548 Caspase-8 Human genes 0.000 description 1
- 108090000538 Caspase-8 Proteins 0.000 description 1
- 102100026550 Caspase-9 Human genes 0.000 description 1
- 108090000566 Caspase-9 Proteins 0.000 description 1
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
- 241000252506 Characiformes Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 102000002554 Cyclin A Human genes 0.000 description 1
- 108010068192 Cyclin A Proteins 0.000 description 1
- 102000002427 Cyclin B Human genes 0.000 description 1
- 108010068150 Cyclin B Proteins 0.000 description 1
- 102000003910 Cyclin D Human genes 0.000 description 1
- 108090000259 Cyclin D Proteins 0.000 description 1
- 102000003909 Cyclin E Human genes 0.000 description 1
- 108090000257 Cyclin E Proteins 0.000 description 1
- 102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
- 108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 108091006052 GFP-tagged proteins Proteins 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 102000003964 Histone deacetylase Human genes 0.000 description 1
- 108090000353 Histone deacetylase Proteins 0.000 description 1
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
- 101001005128 Homo sapiens LIM domain kinase 1 Proteins 0.000 description 1
- 101000891649 Homo sapiens Transcription elongation factor A protein-like 1 Proteins 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102100026023 LIM domain kinase 1 Human genes 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- 102100021760 Magnesium transporter protein 1 Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101000596402 Mus musculus Neuronal vesicle trafficking-associated protein 1 Proteins 0.000 description 1
- 101000800539 Mus musculus Translationally-controlled tumor protein Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000005640 Myosin Type II Human genes 0.000 description 1
- 108010045128 Myosin Type II Proteins 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- NWSOKOJWKWNSAF-UHFFFAOYSA-N O=C(Sc1nnn[nH]1)c1ccccc1 Chemical compound O=C(Sc1nnn[nH]1)c1ccccc1 NWSOKOJWKWNSAF-UHFFFAOYSA-N 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 101150037263 PIP2 gene Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 101150111584 RHOA gene Proteins 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 108091007602 SLC58A1 Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100262439 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) UBA2 gene Proteins 0.000 description 1
- 101000781972 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Protein wos2 Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 102100022433 Single-stranded DNA cytosine deaminase Human genes 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101710182223 Toxin B Proteins 0.000 description 1
- 101001009610 Toxoplasma gondii Dense granule protein 5 Proteins 0.000 description 1
- 102100040250 Transcription elongation factor A protein-like 1 Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- ILDJYIDXESUBOE-HSCHXYMDSA-N Trp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N ILDJYIDXESUBOE-HSCHXYMDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
- 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 102000035181 adaptor proteins Human genes 0.000 description 1
- 108091005764 adaptor proteins Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- LJWBIAMZBJWAOW-UHFFFAOYSA-N benzhydryloxysilane Chemical compound C=1C=CC=CC=1C(O[SiH3])C1=CC=CC=C1 LJWBIAMZBJWAOW-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940053031 botulinum toxin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008235 cell cycle pathway Effects 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 238000010822 cell death assay Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- YMSPGTPAUQSMNF-UHFFFAOYSA-N chloro-dimethyl-(1,2,2,3,3-pentafluoro-1-phenylpropyl)silane Chemical compound FC(C(C([Si](Cl)(C)C)(C1=CC=CC=C1)F)(F)F)F YMSPGTPAUQSMNF-UHFFFAOYSA-N 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000013499 data model Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000006477 desulfuration reaction Methods 0.000 description 1
- 230000023556 desulfurization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- HHBOIIOOTUCYQD-UHFFFAOYSA-N ethoxy-dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(C)CCCOCC1CO1 HHBOIIOOTUCYQD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000009650 gentamicin protection assay Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229920000140 heteropolymer Polymers 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000005931 immune cell recruitment Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000005339 levitation Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 210000003712 lysosome Anatomy 0.000 description 1
- 230000001868 lysosomic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- ONCZDRURRATYFI-QTCHDTBASA-N methyl (2z)-2-methoxyimino-2-[2-[[(e)-1-[3-(trifluoromethyl)phenyl]ethylideneamino]oxymethyl]phenyl]acetate Chemical compound CO\N=C(/C(=O)OC)C1=CC=CC=C1CO\N=C(/C)C1=CC=CC(C(F)(F)F)=C1 ONCZDRURRATYFI-QTCHDTBASA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000009448 modified atmosphere packaging Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 238000007481 next generation sequencing Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000010627 oxidative phosphorylation Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229940089951 perfluorooctyl triethoxysilane Drugs 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000013047 polymeric layer Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000010379 pull-down assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000011506 response to oxidative stress Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 238000006351 sulfination reaction Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- PISDRBMXQBSCIP-UHFFFAOYSA-N trichloro(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CC[Si](Cl)(Cl)Cl PISDRBMXQBSCIP-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 1
- 239000005052 trichlorosilane Substances 0.000 description 1
- AVYKQOAMZCAHRG-UHFFFAOYSA-N triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane Chemical compound CCO[Si](OCC)(OCC)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F AVYKQOAMZCAHRG-UHFFFAOYSA-N 0.000 description 1
- KVZXHYHCKBTBNP-UHFFFAOYSA-N triethyl(octadecyl)silane Chemical compound CCCCCCCCCCCCCCCCCC[Si](CC)(CC)CC KVZXHYHCKBTBNP-UHFFFAOYSA-N 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- XFVUECRWXACELC-UHFFFAOYSA-N trimethyl oxiran-2-ylmethyl silicate Chemical compound CO[Si](OC)(OC)OCC1CO1 XFVUECRWXACELC-UHFFFAOYSA-N 0.000 description 1
- AXJAWMUPFHKOHY-UHFFFAOYSA-N trimethyl(octadecyl)silane Chemical compound CCCCCCCCCCCCCCCCCC[Si](C)(C)C AXJAWMUPFHKOHY-UHFFFAOYSA-N 0.000 description 1
- 238000005866 tritylation reaction Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/08—Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
- C12N2330/31—Libraries, arrays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562220879P | 2015-09-18 | 2015-09-18 | |
| US62/220,879 | 2015-09-18 | ||
| US201562263548P | 2015-12-04 | 2015-12-04 | |
| US62/263,548 | 2015-12-04 | ||
| US201662354034P | 2016-06-23 | 2016-06-23 | |
| US62/354,034 | 2016-06-23 | ||
| PCT/US2016/052336 WO2017049231A1 (en) | 2015-09-18 | 2016-09-16 | Oligonucleic acid variant libraries and synthesis thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20180050411A true KR20180050411A (ko) | 2018-05-14 |
Family
ID=58276736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187010998A Ceased KR20180050411A (ko) | 2015-09-18 | 2016-09-16 | 올리고핵산 변이체 라이브러리 및 그의 합성 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10844373B2 (enExample) |
| EP (1) | EP3350314A4 (enExample) |
| JP (1) | JP6982362B2 (enExample) |
| KR (1) | KR20180050411A (enExample) |
| CN (1) | CN108368482A (enExample) |
| AU (2) | AU2016324296A1 (enExample) |
| CA (1) | CA2998169A1 (enExample) |
| EA (1) | EA201890763A1 (enExample) |
| GB (1) | GB2557529A (enExample) |
| HK (1) | HK1258869A1 (enExample) |
| IL (1) | IL258164B (enExample) |
| WO (1) | WO2017049231A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9409139B2 (en) | 2013-08-05 | 2016-08-09 | Twist Bioscience Corporation | De novo synthesized gene libraries |
| CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| AU2016324296A1 (en) | 2015-09-18 | 2018-04-12 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| CN108603307A (zh) | 2015-12-01 | 2018-09-28 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
| CA3034769A1 (en) * | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
| CN110248724B (zh) | 2016-09-21 | 2022-11-18 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| CN110366613A (zh) | 2016-12-16 | 2019-10-22 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| WO2018156792A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
| CN110913865A (zh) | 2017-03-15 | 2020-03-24 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| AU2018234624B2 (en) * | 2017-03-15 | 2023-11-16 | Twist Bioscience Corporation | De novo synthesized combinatorial nucleic acid libraries |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for assembling continuous nucleic acids |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| KR102637566B1 (ko) | 2017-10-20 | 2024-02-16 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| CN112041438B (zh) | 2018-01-04 | 2025-05-23 | 特韦斯特生物科学公司 | 基于dna的数字信息存储 |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| CA3124980A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| CN113785057A (zh) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | 用于抗体优化的变异核酸文库 |
| KR20210143766A (ko) | 2019-02-26 | 2021-11-29 | 트위스트 바이오사이언스 코포레이션 | Glp1 수용체에 대한 변이체 핵산 라이브러리 |
| JP2022550497A (ja) | 2019-06-21 | 2022-12-02 | ツイスト バイオサイエンス コーポレーション | バーコードに基づいた核酸配列アセンブリ |
| AU2020355027A1 (en) | 2019-09-23 | 2022-04-21 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| CA3155629A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for crth2 |
| CA3177029A1 (en) | 2020-04-27 | 2021-11-04 | Aaron Sato | Variant nucleic acid libraries for coronavirus |
| JP2023526280A (ja) | 2020-05-15 | 2023-06-21 | コーデックス ディーエヌエー インコーポレイテッド | ポリヌクレオチド配列のオンデマンド合成 |
| US12391762B2 (en) | 2020-08-26 | 2025-08-19 | Twist Bioscience Corporation | Methods and compositions relating to GLP1R variants |
| US11970697B2 (en) | 2020-10-19 | 2024-04-30 | Twist Bioscience Corporation | Methods of synthesizing oligonucleotides using tethered nucleotides |
| EP4281112A4 (en) | 2021-01-21 | 2025-01-15 | Twist Bioscience Corporation | METHODS AND COMPOSITIONS RELATING TO ADENOSINE RECEPTORS |
| US12258406B2 (en) | 2021-03-24 | 2025-03-25 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| EP4334515A1 (en) * | 2021-05-03 | 2024-03-13 | Twist Bioscience Corporation | Variant nucleic acid libraries for glycans |
| WO2022271884A2 (en) | 2021-06-22 | 2022-12-29 | Twist Bioscience Corporation | Methods and compositions relating to covid antibody epitopes |
| AU2022390457A1 (en) | 2021-11-18 | 2024-06-20 | Twist Bioscience Corporation | Dickkopf-1 variant antibodies and methods of use |
| WO2023130123A2 (en) | 2022-01-03 | 2023-07-06 | Twist Bioscience Corporation | Bispecific sars-cov-2 antibodies and methods of use |
Family Cites Families (936)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3549368A (en) | 1968-07-02 | 1970-12-22 | Ibm | Process for improving photoresist adhesion |
| US3920714A (en) | 1972-11-16 | 1975-11-18 | Weber Heinrich | Process for the production of polymeric hydrocarbons with reactive silyl side groups |
| GB1550867A (en) | 1975-08-04 | 1979-08-22 | Hughes Aircraft Co | Positioning method and apparatus for fabricating microcircuit devices |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| EP0090789A1 (en) | 1982-03-26 | 1983-10-05 | Monsanto Company | Chemical DNA synthesis |
| US4994373A (en) | 1983-01-27 | 1991-02-19 | Enzo Biochem, Inc. | Method and structures employing chemically-labelled polynucleotide probes |
| JPS59224123A (ja) | 1983-05-20 | 1984-12-17 | Oki Electric Ind Co Ltd | ウエハアライメントマ−ク |
| US5118605A (en) | 1984-10-16 | 1992-06-02 | Chiron Corporation | Polynucleotide determination with selectable cleavage sites |
| JPS61141761A (ja) | 1984-12-12 | 1986-06-28 | Kanegafuchi Chem Ind Co Ltd | 硬化性組成物 |
| US5242794A (en) | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| US4613398A (en) | 1985-06-06 | 1986-09-23 | International Business Machines Corporation | Formation of etch-resistant resists through preferential permeation |
| US4981797A (en) | 1985-08-08 | 1991-01-01 | Life Technologies, Inc. | Process of producing highly transformable cells and cells produced thereby |
| US4726877A (en) | 1986-01-22 | 1988-02-23 | E. I. Du Pont De Nemours And Company | Methods of using photosensitive compositions containing microgels |
| US4808511A (en) | 1987-05-19 | 1989-02-28 | International Business Machines Corporation | Vapor phase photoresist silylation process |
| JPH07113774B2 (ja) | 1987-05-29 | 1995-12-06 | 株式会社日立製作所 | パタ−ンの形成方法 |
| US4988617A (en) | 1988-03-25 | 1991-01-29 | California Institute Of Technology | Method of detecting a nucleotide change in nucleic acids |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| ATE143696T1 (de) | 1989-02-28 | 1996-10-15 | Canon Kk | Partiell doppelsträngiges oligonukleotid und verfahren zu seiner bildung |
| US5556750A (en) | 1989-05-12 | 1996-09-17 | Duke University | Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
| US5459039A (en) | 1989-05-12 | 1995-10-17 | Duke University | Methods for mapping genetic mutations |
| US6008031A (en) | 1989-05-12 | 1999-12-28 | Duke University | Method of analysis and manipulation of DNA utilizing mismatch repair systems |
| US5102797A (en) | 1989-05-26 | 1992-04-07 | Dna Plant Technology Corporation | Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5242974A (en) | 1991-11-22 | 1993-09-07 | Affymax Technologies N.V. | Polymer reversal on solid surfaces |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US6919211B1 (en) | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
| US6309822B1 (en) | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| CA2036946C (en) | 1990-04-06 | 2001-10-16 | Kenneth V. Deugau | Indexing linkers |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US6087482A (en) | 1990-07-27 | 2000-07-11 | Isis Pharmaceuticals, Inc. | Heteroatomic oligonucleoside linkages |
| AU8871891A (en) | 1990-09-27 | 1992-04-28 | Invitrogen Corporation | Direct cloning of pcr amplified nucleic acids |
| GB9025236D0 (en) | 1990-11-20 | 1991-01-02 | Secr Defence | Silicon-on porous-silicon;method of production |
| DE69132905T2 (de) | 1990-12-06 | 2002-08-01 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Detektion von Nukleinsäuresequenzen |
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| DE69132531T2 (de) | 1990-12-06 | 2001-09-13 | Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) | Verbindungen und ihre Verwendung in einer binären Synthesestrategie |
| US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
| US5137814A (en) | 1991-06-14 | 1992-08-11 | Life Technologies, Inc. | Use of exo-sample nucleotides in gene cloning |
| US5449754A (en) | 1991-08-07 | 1995-09-12 | H & N Instruments, Inc. | Generation of combinatorial libraries |
| US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
| US6759226B1 (en) | 2000-05-24 | 2004-07-06 | Third Wave Technologies, Inc. | Enzymes for the detection of specific nucleic acid sequences |
| US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
| US7150982B2 (en) | 1991-09-09 | 2006-12-19 | Third Wave Technologies, Inc. | RNA detection assays |
| US5994069A (en) | 1996-01-24 | 1999-11-30 | Third Wave Technologies, Inc. | Detection of nucleic acids by multiple sequential invasive cleavages |
| US7045289B2 (en) | 1991-09-09 | 2006-05-16 | Third Wave Technologies, Inc. | Detection of RNA Sequences |
| AU675054B2 (en) | 1991-11-22 | 1997-01-23 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| DE69322266T2 (de) | 1992-04-03 | 1999-06-02 | Perkin-Elmer Corp., Foster City, Calif. | Proben zusammensetzung und verfahren |
| JP2553322Y2 (ja) | 1992-05-11 | 1997-11-05 | サンデン株式会社 | 飲料抽出装置のフィルタ送り機構 |
| CA2141450A1 (en) | 1992-07-31 | 1994-02-17 | Maureen Laney | Method for introducing defined sequences at the 3' end of polynucleotides |
| US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
| JP3176444B2 (ja) | 1992-10-01 | 2001-06-18 | 株式会社リコー | 水性インク及びこれを用いた記録方法 |
| DE4241045C1 (de) | 1992-12-05 | 1994-05-26 | Bosch Gmbh Robert | Verfahren zum anisotropen Ätzen von Silicium |
| US5368823A (en) | 1993-02-11 | 1994-11-29 | University Of Georgia Research Foundation, Inc. | Automated synthesis of oligonucleotides |
| US5395753A (en) | 1993-02-19 | 1995-03-07 | Theratech, Inc. | Method for diagnosing rheumatoid arthritis |
| AU684279B2 (en) | 1993-04-12 | 1997-12-11 | Northwestern University | Method of forming oligonucleotides |
| US7135312B2 (en) | 1993-04-15 | 2006-11-14 | University Of Rochester | Circular DNA vectors for synthesis of RNA and DNA |
| US5455239A (en) | 1993-08-05 | 1995-10-03 | Merck & Co. Inc. | 3-aryl of heteroaryl-7-heteroaralkylamido cephalosporin compounds, compositions and methods of use |
| US5482845A (en) | 1993-09-24 | 1996-01-09 | The Trustees Of Columbia University In The City Of New York | Method for construction of normalized cDNA libraries |
| CN1039623C (zh) | 1993-10-22 | 1998-09-02 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种防治运动病综合征的药物组合物及其制备方法 |
| CA2174140C (en) | 1993-10-28 | 2004-04-06 | Kenneth L. Beattie | Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
| US6893816B1 (en) | 1993-10-28 | 2005-05-17 | Houston Advanced Research Center | Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
| US6027877A (en) | 1993-11-04 | 2000-02-22 | Gene Check, Inc. | Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
| EP1637596B1 (en) | 1994-03-29 | 2011-05-18 | Novozymes A/S | Alkaline bacillus amylase |
| US5514789A (en) | 1994-04-21 | 1996-05-07 | Barrskogen, Inc. | Recovery of oligonucleotides by gas phase cleavage |
| SE512382C2 (sv) | 1994-04-26 | 2000-03-06 | Ericsson Telefon Ab L M | Anordning och förfarande för att placera långsträckta element mot eller invid en yta |
| AU698953B2 (en) | 1994-04-29 | 1998-11-12 | Applied Biosystems, Llc | System for real time detection of nucleic acid amplification products |
| US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| AU689924B2 (en) | 1994-06-23 | 1998-04-09 | Affymax Technologies N.V. | Photolabile compounds and methods for their use |
| US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
| US5530516A (en) | 1994-10-04 | 1996-06-25 | Tamarack Scientific Co., Inc. | Large-area projection exposure system |
| US6635226B1 (en) | 1994-10-19 | 2003-10-21 | Agilent Technologies, Inc. | Microanalytical device and use thereof for conducting chemical processes |
| US6613560B1 (en) | 1994-10-19 | 2003-09-02 | Agilent Technologies, Inc. | PCR microreactor for amplifying DNA using microquantities of sample fluid |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| JPH11511900A (ja) | 1994-11-22 | 1999-10-12 | コンプレツクス フルイツド システムズ,インコーポレーテツド | マイクロエレクトロニクス用途のための非アミン系フォトレジスト密着促進剤 |
| US5688642A (en) | 1994-12-01 | 1997-11-18 | The United States Of America As Represented By The Secretary Of The Navy | Selective attachment of nucleic acid molecules to patterned self-assembled surfaces |
| US6017434A (en) | 1995-05-09 | 2000-01-25 | Curagen Corporation | Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments |
| US5830655A (en) | 1995-05-22 | 1998-11-03 | Sri International | Oligonucleotide sizing using cleavable primers |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US6446682B1 (en) | 1995-06-06 | 2002-09-10 | James P. Viken | Auto-loading fluid exchanger and method of use |
| US5877280A (en) | 1995-06-06 | 1999-03-02 | The Mount Sinai School Of Medicine Of The City University Of New York | Thermostable muts proteins |
| US5707806A (en) | 1995-06-07 | 1998-01-13 | Genzyme Corporation | Direct sequence identification of mutations by cleavage- and ligation-associated mutation-specific sequencing |
| US5780613A (en) | 1995-08-01 | 1998-07-14 | Northwestern University | Covalent lock for self-assembled oligonucleotide constructs |
| US5712126A (en) | 1995-08-01 | 1998-01-27 | Yale University | Analysis of gene expression by display of 3-end restriction fragments of CDNA |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
| US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
| CA2240346C (en) | 1995-12-15 | 2007-04-24 | Amersham Life Science, Inc. | Methods for the detection and removal of mutant sequences that arise during enzymatic amplification using mismatch repair systems |
| US5962271A (en) | 1996-01-03 | 1999-10-05 | Cloutech Laboratories, Inc. | Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
| US5976846A (en) | 1996-01-13 | 1999-11-02 | Passmore; Steven E. | Method for multifragment in vivo cloning and mutation mapping |
| US5985557A (en) | 1996-01-24 | 1999-11-16 | Third Wave Technologies, Inc. | Invasive cleavage of nucleic acids |
| US7122364B1 (en) | 1998-03-24 | 2006-10-17 | Third Wave Technologies, Inc. | FEN endonucleases |
| US7527928B2 (en) | 1996-11-29 | 2009-05-05 | Third Wave Technologies, Inc. | Reactions on a solid surface |
| US6706471B1 (en) | 1996-01-24 | 2004-03-16 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
| US7432048B2 (en) | 1996-11-29 | 2008-10-07 | Third Wave Technologies, Inc. | Reactions on a solid surface |
| US6090606A (en) | 1996-01-24 | 2000-07-18 | Third Wave Technologies, Inc. | Cleavage agents |
| US6274369B1 (en) | 1996-02-02 | 2001-08-14 | Invitrogen Corporation | Method capable of increasing competency of bacterial cell transformation |
| US6013440A (en) | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
| US6020481A (en) | 1996-04-01 | 2000-02-01 | The Perkin-Elmer Corporation | Asymmetric benzoxanthene dyes |
| US6706875B1 (en) | 1996-04-17 | 2004-03-16 | Affyemtrix, Inc. | Substrate preparation process |
| US5869245A (en) | 1996-06-05 | 1999-02-09 | Fox Chase Cancer Center | Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands |
| US5863801A (en) | 1996-06-14 | 1999-01-26 | Sarnoff Corporation | Automated nucleic acid isolation |
| US6780982B2 (en) | 1996-07-12 | 2004-08-24 | Third Wave Technologies, Inc. | Charge tags and the separation of nucleic acid molecules |
| US5853993A (en) | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| WO1998022541A2 (en) | 1996-11-08 | 1998-05-28 | Ikonos Corporation | Method for coating substrates |
| US5750672A (en) | 1996-11-22 | 1998-05-12 | Barrskogen, Inc. | Anhydrous amine cleavage of oligonucleotides |
| ATE530652T1 (de) | 1996-11-29 | 2011-11-15 | Third Wave Tech Inc | Fen-1-endonucleasen, mischungen und spaltungsverfahren |
| EP0990142A4 (en) | 1996-12-31 | 2000-09-27 | Genometrix Genomics Inc | MULTIPLEXED MOLECULAR ANALYSIS METHOD AND DEVICE |
| JP2001512310A (ja) | 1997-02-12 | 2001-08-21 | ライフ テクノロジーズ,インコーポレイテッド | コンピテント細胞を凍結乾燥するための方法 |
| US5882496A (en) | 1997-02-27 | 1999-03-16 | The Regents Of The University Of California | Porous silicon structures with high surface area/specific pore size |
| US6770748B2 (en) | 1997-03-07 | 2004-08-03 | Takeshi Imanishi | Bicyclonucleoside and oligonucleotide analogue |
| US6419883B1 (en) | 1998-01-16 | 2002-07-16 | University Of Washington | Chemical synthesis using solvent microdroplets |
| WO1998041531A2 (en) | 1997-03-20 | 1998-09-24 | University Of Washington | Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
| US6028189A (en) | 1997-03-20 | 2000-02-22 | University Of Washington | Solvent for oligonucleotide synthesis and methods of use |
| DE69838724T2 (de) | 1997-03-21 | 2008-10-30 | Stratagene California, La Jolla | Polymerase-verbessernder faktor (pef)-enthaltende extrakte, pef proteinkomplexe, isoliertes pef protein und verfahren zur reinigung und identifizierung |
| US6969488B2 (en) | 1998-05-22 | 2005-11-29 | Solexa, Inc. | System and apparatus for sequential processing of analytes |
| US5922593A (en) | 1997-05-23 | 1999-07-13 | Becton, Dickinson And Company | Microbiological test panel and method therefor |
| EP0991930B1 (en) | 1997-06-26 | 2004-06-16 | Perseptive Biosystems, Inc. | High density sample holder for analysis of biological samples |
| GB9714716D0 (en) | 1997-07-11 | 1997-09-17 | Brax Genomics Ltd | Characterising nucleic acids |
| US5989872A (en) | 1997-08-12 | 1999-11-23 | Clontech Laboratories, Inc. | Methods and compositions for transferring DNA sequence information among vectors |
| US6027898A (en) | 1997-08-18 | 2000-02-22 | Transgenomic, Inc. | Chromatographic method for mutation detection using mutation site specifically acting enzymes and chemicals |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| US6136568A (en) | 1997-09-15 | 2000-10-24 | Hiatt; Andrew C. | De novo polynucleotide synthesis using rolling templates |
| DE69841578D1 (de) | 1997-09-16 | 2010-05-06 | Centocor Inc | Methoden zur kompletten chemischen Synthese und Zusammensetzung von Genen und Genomen |
| US6670127B2 (en) | 1997-09-16 | 2003-12-30 | Egea Biosciences, Inc. | Method for assembly of a polynucleotide encoding a target polypeptide |
| US5976842A (en) | 1997-10-30 | 1999-11-02 | Clontech Laboratories, Inc. | Methods and compositions for use in high fidelity polymerase chain reaction |
| US8182991B1 (en) | 1997-11-26 | 2012-05-22 | Third Wave Technologies, Inc. | FEN-1 endonucleases, mixtures and cleavage methods |
| US6408308B1 (en) | 1998-01-29 | 2002-06-18 | Incyte Pharmaceuticals, Inc. | System and method for generating, analyzing and storing normalized expression datasets from raw expression datasets derived from microarray includes nucleic acid probe sequences |
| US6287776B1 (en) | 1998-02-02 | 2001-09-11 | Signature Bioscience, Inc. | Method for detecting and classifying nucleic acid hybridization |
| US6251588B1 (en) | 1998-02-10 | 2001-06-26 | Agilent Technologies, Inc. | Method for evaluating oligonucleotide probe sequences |
| US6426184B1 (en) | 1998-02-11 | 2002-07-30 | The Regents Of The University Of Michigan | Method and apparatus for chemical and biochemical reactions using photo-generated reagents |
| CA2321070C (en) | 1998-02-23 | 2010-04-06 | Wisconsin Alumni Research Foundation | Method and apparatus for synthesis of arrays of dna probes |
| JP4493844B2 (ja) | 1998-03-25 | 2010-06-30 | ランデグレン、ウルフ | 錠型(padlock)プローブのローリングサークル複製 |
| US6284497B1 (en) | 1998-04-09 | 2001-09-04 | Trustees Of Boston University | Nucleic acid arrays and methods of synthesis |
| US7321828B2 (en) | 1998-04-13 | 2008-01-22 | Isis Pharmaceuticals, Inc. | System of components for preparing oligonucleotides |
| AU762397B2 (en) | 1998-04-13 | 2003-06-26 | Isis Pharmaceuticals, Inc. | Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| US6376285B1 (en) | 1998-05-28 | 2002-04-23 | Texas Instruments Incorporated | Annealed porous silicon with epitaxial layer for SOI |
| US6274725B1 (en) | 1998-06-02 | 2001-08-14 | Isis Pharmaceuticals, Inc. | Activators for oligonucleotide synthesis |
| US6130045A (en) | 1998-06-11 | 2000-10-10 | Clontech Laboratories, Inc. | Thermostable polymerase |
| US6251595B1 (en) | 1998-06-18 | 2001-06-26 | Agilent Technologies, Inc. | Methods and devices for carrying out chemical reactions |
| DE69928995T2 (de) | 1998-06-22 | 2006-09-07 | Affymetrix, Inc., Santa Clara | Reagenz und Verfahren zu fester Phase Synthese |
| US7399844B2 (en) | 1998-07-09 | 2008-07-15 | Agilent Technologies, Inc. | Method and reagents for analyzing the nucleotide sequence of nucleic acids |
| US6218118B1 (en) | 1998-07-09 | 2001-04-17 | Agilent Technologies, Inc. | Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry |
| US6787308B2 (en) | 1998-07-30 | 2004-09-07 | Solexa Ltd. | Arrayed biomolecules and their use in sequencing |
| US20030022207A1 (en) | 1998-10-16 | 2003-01-30 | Solexa, Ltd. | Arrayed polynucleotides and their use in genome analysis |
| US6222030B1 (en) | 1998-08-03 | 2001-04-24 | Agilent Technologies, Inc. | Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection |
| US6951719B1 (en) | 1999-08-11 | 2005-10-04 | Proteus S.A. | Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained |
| US6991922B2 (en) | 1998-08-12 | 2006-01-31 | Proteus S.A. | Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation |
| US6107038A (en) | 1998-08-14 | 2000-08-22 | Agilent Technologies Inc. | Method of binding a plurality of chemicals on a substrate by electrophoretic self-assembly |
| EP1405666B1 (de) | 1998-08-28 | 2007-03-21 | febit biotech GmbH | Träger für Analytbestimmungsverfahren und Verfahren zur Herstellung des Trägers |
| US6258454B1 (en) | 1998-09-01 | 2001-07-10 | Agilent Technologies Inc. | Functionalization of substrate surfaces with silane mixtures |
| US6461812B2 (en) | 1998-09-09 | 2002-10-08 | Agilent Technologies, Inc. | Method and multiple reservoir apparatus for fabrication of biomolecular arrays |
| US6458583B1 (en) | 1998-09-09 | 2002-10-01 | Agilent Technologies, Inc. | Method and apparatus for making nucleic acid arrays |
| CA2342838A1 (en) | 1998-09-15 | 2000-03-23 | Yale University | Molecular cloning using rolling circle amplification |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| US6399516B1 (en) | 1998-10-30 | 2002-06-04 | Massachusetts Institute Of Technology | Plasma etch techniques for fabricating silicon structures from a substrate |
| US6309828B1 (en) | 1998-11-18 | 2001-10-30 | Agilent Technologies, Inc. | Method and apparatus for fabricating replicate arrays of nucleic acid molecules |
| GB9900298D0 (en) | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
| AU2415200A (en) | 1999-01-18 | 2000-08-01 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| JP2002534966A (ja) | 1999-01-19 | 2002-10-22 | マキシジェン, インコーポレイテッド | オリゴヌクレオチド媒介核酸組換え |
| US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6251685B1 (en) | 1999-02-18 | 2001-06-26 | Agilent Technologies, Inc. | Readout method for molecular biological electronically addressable arrays |
| ATE334197T1 (de) | 1999-02-19 | 2006-08-15 | Febit Biotech Gmbh | Verfahren zur herstellung von polymeren |
| US6632655B1 (en) | 1999-02-23 | 2003-10-14 | Caliper Technologies Corp. | Manipulation of microparticles in microfluidic systems |
| EP1159285B1 (en) | 1999-03-08 | 2005-05-25 | Metrigen, Inc. | Methods and compositions for economically synthesizing and assembling long dna sequences |
| US6824866B1 (en) | 1999-04-08 | 2004-11-30 | Affymetrix, Inc. | Porous silica substrates for polymer synthesis and assays |
| US6284465B1 (en) | 1999-04-15 | 2001-09-04 | Agilent Technologies, Inc. | Apparatus, systems and method for locating nucleic acids bound to surfaces |
| US6469156B1 (en) | 1999-04-20 | 2002-10-22 | The United States Of America As Represented By The Department Of Health And Human Services | Rapid and sensitive method for detecting histoplasma capsulatum |
| US6773676B2 (en) | 1999-04-27 | 2004-08-10 | Agilent Technologies, Inc. | Devices for performing array hybridization assays and methods of using the same |
| US6518056B2 (en) | 1999-04-27 | 2003-02-11 | Agilent Technologies Inc. | Apparatus, systems and method for assaying biological materials using an annular format |
| US6221653B1 (en) | 1999-04-27 | 2001-04-24 | Agilent Technologies, Inc. | Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids |
| US6300137B1 (en) | 1999-04-28 | 2001-10-09 | Agilent Technologies Inc. | Method for synthesizing a specific, surface-bound polymer uniformly over an element of a molecular array |
| US6242266B1 (en) | 1999-04-30 | 2001-06-05 | Agilent Technologies Inc. | Preparation of biopolymer arrays |
| US6323043B1 (en) | 1999-04-30 | 2001-11-27 | Agilent Technologies, Inc. | Fabricating biopolymer arrays |
| US7276336B1 (en) | 1999-07-22 | 2007-10-02 | Agilent Technologies, Inc. | Methods of fabricating an addressable array of biopolymer probes |
| CA2368679C (en) | 1999-05-01 | 2010-11-09 | Qinetiq Limited | Derivatized porous silicon |
| ATE347617T1 (de) | 1999-05-06 | 2006-12-15 | Sinai School Medicine | Steganographie auf dna basis |
| US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
| WO2000071559A1 (en) | 1999-05-24 | 2000-11-30 | Invitrogen Corporation | Method for deblocking of labeled oligonucleotides |
| US6472147B1 (en) | 1999-05-25 | 2002-10-29 | The Scripps Research Institute | Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| US6132997A (en) | 1999-05-28 | 2000-10-17 | Agilent Technologies | Method for linear mRNA amplification |
| US6815218B1 (en) | 1999-06-09 | 2004-11-09 | Massachusetts Institute Of Technology | Methods for manufacturing bioelectronic devices |
| US6709852B1 (en) | 1999-06-22 | 2004-03-23 | Invitrogen Corporation | Rapid growing microorganisms for biotechnology applications |
| CA2377707A1 (en) | 1999-06-22 | 2000-12-28 | Invitrogen Corporation | Improved primers and methods for the detection and discrimination of nucleic acids |
| DE19928410C2 (de) | 1999-06-22 | 2002-11-28 | Agilent Technologies Inc | Gerätegehäuse mit einer Einrichtung zum Betrieb eines Labor-Mikrochips |
| US6399394B1 (en) | 1999-06-30 | 2002-06-04 | Agilent Technologies, Inc. | Testing multiple fluid samples with multiple biopolymer arrays |
| US6465183B2 (en) | 1999-07-01 | 2002-10-15 | Agilent Technologies, Inc. | Multidentate arrays |
| US7504213B2 (en) | 1999-07-09 | 2009-03-17 | Agilent Technologies, Inc. | Methods and apparatus for preparing arrays comprising features having degenerate biopolymers |
| US6461816B1 (en) | 1999-07-09 | 2002-10-08 | Agilent Technologies, Inc. | Methods for controlling cross-hybridization in analysis of nucleic acid sequences |
| US6346423B1 (en) | 1999-07-16 | 2002-02-12 | Agilent Technologies, Inc. | Methods and compositions for producing biopolymeric arrays |
| US6306599B1 (en) | 1999-07-16 | 2001-10-23 | Agilent Technologies Inc. | Biopolymer arrays and their fabrication |
| US6201112B1 (en) | 1999-07-22 | 2001-03-13 | Agilent Technologies Inc. | Method for 3′ end-labeling ribonucleic acids |
| US6180351B1 (en) | 1999-07-22 | 2001-01-30 | Agilent Technologies Inc. | Chemical array fabrication with identifier |
| WO2001012862A2 (en) | 1999-08-18 | 2001-02-22 | Illumina, Inc. | Compositions and methods for preparing oligonucleotide solutions |
| US6262490B1 (en) | 1999-11-05 | 2001-07-17 | Advanced Semiconductor Engineering, Inc. | Substrate strip for use in packaging semiconductor chips |
| US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US6743585B2 (en) | 1999-09-16 | 2004-06-01 | Agilent Technologies, Inc. | Methods for preparing conjugates |
| US6319674B1 (en) | 1999-09-16 | 2001-11-20 | Agilent Technologies, Inc. | Methods for attaching substances to surfaces |
| US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US7078167B2 (en) | 1999-09-17 | 2006-07-18 | Agilent Technologies, Inc. | Arrays having background features and methods for using the same |
| US7122303B2 (en) | 1999-09-17 | 2006-10-17 | Agilent Technologies, Inc. | Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same |
| EP1218543A2 (en) | 1999-09-29 | 2002-07-03 | Solexa Ltd. | Polynucleotide sequencing |
| DE19947495C2 (de) | 1999-10-01 | 2003-05-28 | Agilent Technologies Inc | Mikrofluidischer Mikrochip |
| EP1235932A2 (en) | 1999-10-08 | 2002-09-04 | Protogene Laboratories, Inc. | Method and apparatus for performing large numbers of reactions using array assembly |
| US6232072B1 (en) | 1999-10-15 | 2001-05-15 | Agilent Technologies, Inc. | Biopolymer array inspection |
| US6451998B1 (en) | 1999-10-18 | 2002-09-17 | Agilent Technologies, Inc. | Capping and de-capping during oligonucleotide synthesis |
| US6171797B1 (en) | 1999-10-20 | 2001-01-09 | Agilent Technologies Inc. | Methods of making polymeric arrays |
| US6387636B1 (en) | 1999-10-22 | 2002-05-14 | Agilent Technologies, Inc. | Method of shielding biosynthesis reactions from the ambient environment on an array |
| US7115423B1 (en) | 1999-10-22 | 2006-10-03 | Agilent Technologies, Inc. | Fluidic structures within an array package |
| US6077674A (en) | 1999-10-27 | 2000-06-20 | Agilent Technologies Inc. | Method of producing oligonucleotide arrays with features of high purity |
| US6329210B1 (en) | 1999-10-29 | 2001-12-11 | Agilent Technologies, Inc. | Method and apparatus for high volume polymer synthesis |
| US6689319B1 (en) | 1999-10-29 | 2004-02-10 | Agilent Technologies, Ind. | Apparatus for deposition and inspection of chemical and biological fluids |
| US6406849B1 (en) | 1999-10-29 | 2002-06-18 | Agilent Technologies, Inc. | Interrogating multi-featured arrays |
| US8268605B2 (en) | 1999-10-29 | 2012-09-18 | Agilent Technologies, Inc. | Compositions and methods utilizing DNA polymerases |
| US20010055761A1 (en) | 1999-10-29 | 2001-12-27 | Agilent Technologies | Small scale dna synthesis using polymeric solid support with functionalized regions |
| US6428957B1 (en) | 1999-11-08 | 2002-08-06 | Agilent Technologies, Inc. | Systems tools and methods of assaying biological materials using spatially-addressable arrays |
| US6440669B1 (en) | 1999-11-10 | 2002-08-27 | Agilent Technologies, Inc. | Methods for applying small volumes of reagents |
| US7041445B2 (en) | 1999-11-15 | 2006-05-09 | Clontech Laboratories, Inc. | Long oligonucleotide arrays |
| US6446642B1 (en) | 1999-11-22 | 2002-09-10 | Agilent Technologies, Inc. | Method and apparatus to clean an inkjet reagent deposition device |
| US6582938B1 (en) | 2001-05-11 | 2003-06-24 | Affymetrix, Inc. | Amplification of nucleic acids |
| US6800439B1 (en) | 2000-01-06 | 2004-10-05 | Affymetrix, Inc. | Methods for improved array preparation |
| EP1276900A2 (en) | 2000-01-11 | 2003-01-22 | Maxygen, Inc. | Integrated systems and methods for diversity generation and screening |
| EP1118661A1 (en) | 2000-01-13 | 2001-07-25 | Het Nederlands Kanker Instituut | T cell receptor libraries |
| WO2001056216A2 (en) | 2000-01-25 | 2001-08-02 | Affymetrix, Inc. | Method, system and computer software for providing a genomic web portal |
| US6587579B1 (en) | 2000-01-26 | 2003-07-01 | Agilent Technologies Inc. | Feature quality in array fabrication |
| US6406851B1 (en) | 2000-01-28 | 2002-06-18 | Agilent Technologies, Inc. | Method for coating a substrate quickly and uniformly with a small volume of fluid |
| US7198939B2 (en) | 2000-01-28 | 2007-04-03 | Agilent Technologies, Inc. | Apparatus for interrogating an addressable array |
| US6458526B1 (en) | 2000-01-28 | 2002-10-01 | Agilent Technologies, Inc. | Method and apparatus to inhibit bubble formation in a fluid |
| US6235483B1 (en) | 2000-01-31 | 2001-05-22 | Agilent Technologies, Inc. | Methods and kits for indirect labeling of nucleic acids |
| GB0002389D0 (en) | 2000-02-02 | 2000-03-22 | Solexa Ltd | Molecular arrays |
| US6403314B1 (en) | 2000-02-04 | 2002-06-11 | Agilent Technologies, Inc. | Computational method and system for predicting fragmented hybridization and for identifying potential cross-hybridization |
| US6833450B1 (en) | 2000-03-17 | 2004-12-21 | Affymetrix, Inc. | Phosphite ester oxidation in nucleic acid array preparation |
| US6365355B1 (en) | 2000-03-28 | 2002-04-02 | The Regents Of The University Of California | Chimeric proteins for detection and quantitation of DNA mutations, DNA sequence variations, DNA damage and DNA mismatches |
| US20020025561A1 (en) | 2000-04-17 | 2002-02-28 | Hodgson Clague Pitman | Vectors for gene-self-assembly |
| US7776021B2 (en) | 2000-04-28 | 2010-08-17 | The Charles Stark Draper Laboratory | Micromachined bilayer unit for filtration of small molecules |
| US7163660B2 (en) | 2000-05-31 | 2007-01-16 | Infineon Technologies Ag | Arrangement for taking up liquid analytes |
| US6716634B1 (en) | 2000-05-31 | 2004-04-06 | Agilent Technologies, Inc. | Increasing ionization efficiency in mass spectrometry |
| JP2004509609A (ja) | 2000-06-02 | 2004-04-02 | ブルー ヘロン バイオテクノロジー インコーポレイテッド | 合成二本鎖オリゴヌクレオチドの配列忠実度を改善するための方法 |
| US6686193B2 (en) | 2000-07-10 | 2004-02-03 | Vertex Pharmaceuticals, Inc. | High throughput method and system for screening candidate compounds for activity against target ion channels |
| NZ523715A (en) | 2000-07-27 | 2004-07-30 | Univ Australian | A set of oligonucleotide probes 'promiscuous' probes that hybridise to target sequences common to more than one of the target polynucleotides |
| US7135565B2 (en) | 2000-07-28 | 2006-11-14 | Agilent Technologies, Inc. | Synthesis of polynucleotides using combined oxidation/deprotection chemistry |
| US6613893B1 (en) | 2000-07-31 | 2003-09-02 | Agilent Technologies Inc. | Array fabrication |
| US6890760B1 (en) | 2000-07-31 | 2005-05-10 | Agilent Technologies, Inc. | Array fabrication |
| US6599693B1 (en) | 2000-07-31 | 2003-07-29 | Agilent Technologies Inc. | Array fabrication |
| DE60114525T2 (de) | 2000-07-31 | 2006-07-20 | Agilent Technologies Inc., A Delaware Corp., Palo Alto | Array-basierende Methoden zur Synthese von Nukleinsäuregemischen |
| US7205400B2 (en) | 2000-07-31 | 2007-04-17 | Agilent Technologies, Inc. | Array fabrication |
| GB0018876D0 (en) | 2000-08-01 | 2000-09-20 | Applied Research Systems | Method of producing polypeptides |
| CA2421059A1 (en) | 2000-08-24 | 2002-02-28 | Maxygen, Inc. | Constructs and their use in metabolic pathway engineering |
| US20030036066A1 (en) | 2000-09-08 | 2003-02-20 | University Technologies International Inc. | Linker phosphoramidites for oligonucleotide synthesis |
| US6966945B1 (en) | 2000-09-20 | 2005-11-22 | Goodrich Corporation | Inorganic matrix compositions, composites and process of making the same |
| WO2002027029A2 (en) | 2000-09-27 | 2002-04-04 | Lynx Therapeutics, Inc. | Method for determining relative abundance of nucleic acid sequences |
| NO20004869D0 (no) | 2000-09-28 | 2000-09-28 | Torbjoern Rognes | Metode for hurtig optimal lokal sekvensjustering ved bruk av parallell prosessering |
| US7097809B2 (en) | 2000-10-03 | 2006-08-29 | California Institute Of Technology | Combinatorial synthesis system |
| EP1330306A2 (en) | 2000-10-10 | 2003-07-30 | BioTrove, Inc. | Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| US6693187B1 (en) | 2000-10-17 | 2004-02-17 | Lievre Cornu Llc | Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| DE10051396A1 (de) | 2000-10-17 | 2002-04-18 | Febit Ferrarius Biotech Gmbh | Verfahren und Vorrichtung zur integrierten Synthese und Analytbestimmung an einem Träger |
| IL155076A0 (en) | 2000-10-18 | 2003-10-31 | Ultra Proizv Elektronskih Napr | System for payment data exchange and payment terminal device used therein |
| EP1203945B1 (en) | 2000-10-26 | 2006-12-20 | Agilent Technologies, Inc. (a Delaware corporation) | Microarray |
| US6905816B2 (en) | 2000-11-27 | 2005-06-14 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
| US20020155439A1 (en) | 2000-12-04 | 2002-10-24 | Ana Rodriguez | Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction |
| US20040253242A1 (en) | 2000-12-05 | 2004-12-16 | Bowdish Katherine S. | Rationally designed antibodies |
| EP1343802B1 (en) | 2000-12-05 | 2012-05-30 | Avecia Biotechnology Inc | Process for the preparation of oligonucleotides |
| US6768005B2 (en) | 2000-12-20 | 2004-07-27 | Avecia Limited | Process |
| DE10060433B4 (de) | 2000-12-05 | 2006-05-11 | Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. | Verfahren zur Herstellung eines Fluidbauelements, Fluidbauelement und Analysevorrichtung |
| US6660475B2 (en) | 2000-12-15 | 2003-12-09 | New England Biolabs, Inc. | Use of site-specific nicking endonucleases to create single-stranded regions and applications thereof |
| AUPR259301A0 (en) | 2001-01-18 | 2001-02-15 | Polymerat Pty Ltd | Polymers having co-continuous architecture |
| WO2002081490A2 (en) | 2001-01-19 | 2002-10-17 | Egea Biosciences, Inc. | Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| US6958217B2 (en) | 2001-01-24 | 2005-10-25 | Genomic Expression Aps | Single-stranded polynucleotide tags |
| US6879915B2 (en) | 2001-01-31 | 2005-04-12 | Agilent Technologies, Inc. | Chemical array fabrication and use |
| US7166258B2 (en) | 2001-01-31 | 2007-01-23 | Agilent Technologies, Inc. | Automation-optimized microarray package |
| US7027930B2 (en) | 2001-01-31 | 2006-04-11 | Agilent Technologies, Inc. | Reading chemical arrays |
| US20020164824A1 (en) | 2001-02-16 | 2002-11-07 | Jianming Xiao | Method and apparatus based on bundled capillaries for high throughput screening |
| US6660338B1 (en) | 2001-03-08 | 2003-12-09 | Agilent Technologies, Inc. | Functionalization of substrate surfaces with silane mixtures |
| WO2002072864A2 (en) | 2001-03-08 | 2002-09-19 | Applera Corporation | Reagents for oligonucleotide cleavage and deprotection |
| US7211654B2 (en) | 2001-03-14 | 2007-05-01 | Regents Of The University Of Michigan | Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| DK1370690T3 (da) | 2001-03-16 | 2012-07-09 | Kalim Mir | Arrays og fremgangsmåder til anvendelse heraf |
| US6610978B2 (en) | 2001-03-27 | 2003-08-26 | Agilent Technologies, Inc. | Integrated sample preparation, separation and introduction microdevice for inductively coupled plasma mass spectrometry |
| WO2002078947A1 (en) | 2001-04-02 | 2002-10-10 | Prolinx Incorporated | Sensor surfaces for detecting analytes |
| US20030022240A1 (en) | 2001-04-17 | 2003-01-30 | Peizhi Luo | Generation and affinity maturation of antibody library in silico |
| US6943036B2 (en) | 2001-04-30 | 2005-09-13 | Agilent Technologies, Inc. | Error detection in chemical array fabrication |
| CA2446417A1 (en) | 2001-05-03 | 2002-11-14 | Sigma Genosys, L.P. | Methods for assembling protein microarrays |
| EP1392868B2 (en) | 2001-05-18 | 2013-09-04 | Wisconsin Alumni Research Foundation | Method for the synthesis of dna sequences using photo-labile linkers |
| WO2002094846A2 (en) | 2001-05-22 | 2002-11-28 | Parallel Synthesis Technologies, Inc. | Method for in situ, on-chip chemical synthesis |
| US6880576B2 (en) | 2001-06-07 | 2005-04-19 | Nanostream, Inc. | Microfluidic devices for methods development |
| US6613523B2 (en) | 2001-06-29 | 2003-09-02 | Agilent Technologies, Inc. | Method of DNA sequencing using cleavable tags |
| US6649348B2 (en) | 2001-06-29 | 2003-11-18 | Agilent Technologies Inc. | Methods for manufacturing arrays |
| US20040161741A1 (en) | 2001-06-30 | 2004-08-19 | Elazar Rabani | Novel compositions and processes for analyte detection, quantification and amplification |
| US6989267B2 (en) | 2001-07-02 | 2006-01-24 | Agilent Technologies, Inc. | Methods of making microarrays with substrate surfaces having covalently bound polyelectrolyte films |
| US6753145B2 (en) | 2001-07-05 | 2004-06-22 | Agilent Technologies, Inc. | Buffer composition and method for hybridization of microarrays on adsorbed polymer siliceous surfaces |
| US7205399B1 (en) | 2001-07-06 | 2007-04-17 | Sirna Therapeutics, Inc. | Methods and reagents for oligonucleotide synthesis |
| US6702256B2 (en) | 2001-07-17 | 2004-03-09 | Agilent Technologies, Inc. | Flow-switching microdevice |
| US7128876B2 (en) | 2001-07-17 | 2006-10-31 | Agilent Technologies, Inc. | Microdevice and method for component separation in a fluid |
| US7314599B2 (en) | 2001-07-17 | 2008-01-01 | Agilent Technologies, Inc. | Paek embossing and adhesion for microfluidic devices |
| US20030108903A1 (en) | 2001-07-19 | 2003-06-12 | Liman Wang | Multiple word DNA computing on surfaces |
| JP4473573B2 (ja) | 2001-07-26 | 2010-06-02 | ストラタジーン カリフォルニア | 多部位突然変異誘発 |
| US20030130827A1 (en) | 2001-08-10 | 2003-07-10 | Joerg Bentzien | Protein design automation for protein libraries |
| US7371580B2 (en) | 2001-08-24 | 2008-05-13 | Agilent Technologies, Inc. | Use of unstructured nucleic acids in assaying nucleic acid molecules |
| US6682702B2 (en) | 2001-08-24 | 2004-01-27 | Agilent Technologies, Inc. | Apparatus and method for simultaneously conducting multiple chemical reactions |
| JP2003101204A (ja) | 2001-09-25 | 2003-04-04 | Nec Kansai Ltd | 配線基板及び配線基板の製造方法並びに電子部品 |
| US20030082618A1 (en) | 2001-10-15 | 2003-05-01 | Guangshan Li | Methods for detecting genetic aberrations |
| US20050124022A1 (en) | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| US6902921B2 (en) | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| US6858720B2 (en) | 2001-10-31 | 2005-02-22 | Agilent Technologies, Inc. | Method of synthesizing polynucleotides using ionic liquids |
| US7524950B2 (en) | 2001-10-31 | 2009-04-28 | Agilent Technologies, Inc. | Uses of cationic salts for polynucleotide synthesis |
| US6852850B2 (en) | 2001-10-31 | 2005-02-08 | Agilent Technologies, Inc. | Use of ionic liquids for fabrication of polynucleotide arrays |
| US20030087298A1 (en) | 2001-11-02 | 2003-05-08 | Roland Green | Detection of hybridization on oligonucleotide microarray through covalently labeling microarray probe |
| ATE509272T1 (de) | 2001-11-09 | 2011-05-15 | 3Dbiosurfaces Technologies Llc | Substrate mit hochliegendem oberflächenbereich für mikroarrays sowie verfahren zur herstellung davon |
| US7482118B2 (en) | 2001-11-15 | 2009-01-27 | Third Wave Technologies, Inc. | Endonuclease-substrate complexes |
| DK1314783T3 (da) | 2001-11-22 | 2009-03-16 | Sloning Biotechnology Gmbh | Nukleinsyrelinkere og deres anvendelse i gensyntese |
| US20030099952A1 (en) | 2001-11-26 | 2003-05-29 | Roland Green | Microarrays with visible pattern detection |
| WO2003048395A1 (en) | 2001-12-03 | 2003-06-12 | Zymogenetics, Inc. | Methods for the selection and cloning of nucleic acid molecules free of unwanted nucleotide sequence alterations |
| US6927029B2 (en) | 2001-12-03 | 2005-08-09 | Agilent Technologies, Inc. | Surface with tethered polymeric species for binding biomolecules |
| US6838888B2 (en) | 2001-12-13 | 2005-01-04 | Agilent Technologies, Inc. | Flow cell humidity sensor system |
| WO2003054232A2 (en) | 2001-12-13 | 2003-07-03 | Blue Heron Biotechnology, Inc. | Methods for removal of double-stranded oligonucleotides containing sequence errors using mismatch recognition proteins |
| US7932070B2 (en) | 2001-12-21 | 2011-04-26 | Agilent Technologies, Inc. | High fidelity DNA polymerase compositions and uses therefor |
| US7282183B2 (en) | 2001-12-24 | 2007-10-16 | Agilent Technologies, Inc. | Atmospheric control in reaction chambers |
| US6846454B2 (en) | 2001-12-24 | 2005-01-25 | Agilent Technologies, Inc. | Fluid exit in reaction chambers |
| US6790620B2 (en) | 2001-12-24 | 2004-09-14 | Agilent Technologies, Inc. | Small volume chambers |
| US7025324B1 (en) | 2002-01-04 | 2006-04-11 | Massachusetts Institute Of Technology | Gating apparatus and method of manufacture |
| WO2003057924A1 (en) | 2002-01-04 | 2003-07-17 | Board Of Regents, The University Of Texas System | Proofreading, error deletion, and ligation method for synthesis of high-fidelity polynucleotide sequences |
| US20040009498A1 (en) | 2002-01-14 | 2004-01-15 | Diversa Corporation | Chimeric antigen binding molecules and methods for making and using them |
| WO2003060084A2 (en) | 2002-01-14 | 2003-07-24 | Diversa Corporation | Methods for making polynucleotides and purifying double-stranded polynucleotides |
| US6673552B2 (en) | 2002-01-14 | 2004-01-06 | Diversa Corporation | Methods for purifying annealed double-stranded oligonucleotides lacking base pair mismatches or nucleotide gaps |
| US7141368B2 (en) | 2002-01-30 | 2006-11-28 | Agilent Technologies, Inc. | Multi-directional deposition in array fabrication |
| US7422851B2 (en) | 2002-01-31 | 2008-09-09 | Nimblegen Systems, Inc. | Correction for illumination non-uniformity during the synthesis of arrays of oligomers |
| US20040126757A1 (en) | 2002-01-31 | 2004-07-01 | Francesco Cerrina | Method and apparatus for synthesis of arrays of DNA probes |
| US7037659B2 (en) | 2002-01-31 | 2006-05-02 | Nimblegen Systems Inc. | Apparatus for constructing DNA probes having a prismatic and kaleidoscopic light homogenizer |
| US7157229B2 (en) | 2002-01-31 | 2007-01-02 | Nimblegen Systems, Inc. | Prepatterned substrate for optical synthesis of DNA probes |
| US7083975B2 (en) | 2002-02-01 | 2006-08-01 | Roland Green | Microarray synthesis instrument and method |
| US20030148291A1 (en) | 2002-02-05 | 2003-08-07 | Karla Robotti | Method of immobilizing biologically active molecules for assay purposes in a microfluidic format |
| US6728129B2 (en) | 2002-02-19 | 2004-04-27 | The Regents Of The University Of California | Multistate triple-decker dyads in three distinct architectures for information storage applications |
| US6958119B2 (en) | 2002-02-26 | 2005-10-25 | Agilent Technologies, Inc. | Mobile phase gradient generation microfluidic device |
| US6770892B2 (en) | 2002-02-28 | 2004-08-03 | Agilent Technologies, Inc. | Method and system for automated focus-distance determination for molecular array scanners |
| US6929951B2 (en) | 2002-02-28 | 2005-08-16 | Agilent Technologies, Inc. | Method and system for molecular array scanner calibration |
| US6914229B2 (en) | 2002-02-28 | 2005-07-05 | Agilent Technologies, Inc. | Signal offset for prevention of data clipping in a molecular array scanner |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| US6919181B2 (en) | 2002-03-25 | 2005-07-19 | Agilent Technologies, Inc. | Methods for generating ligand arrays |
| CA2478983A1 (en) | 2002-04-01 | 2003-10-16 | Blue Heron Biotechnology, Inc. | Solid phase methods for polynucleotide production |
| EP1350853A1 (en) | 2002-04-05 | 2003-10-08 | ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. | Detection of polymorphisms |
| US6773888B2 (en) | 2002-04-08 | 2004-08-10 | Affymetrix, Inc. | Photoactivatable silane compounds and methods for their synthesis and use |
| WO2003089605A2 (en) | 2002-04-22 | 2003-10-30 | Genencor International, Inc. | Method of creating a library of bacterial clones with varying levels of gene expression |
| GB0209539D0 (en) | 2002-04-26 | 2002-06-05 | Avecia Ltd | Monomer Polymer and process |
| US6946285B2 (en) | 2002-04-29 | 2005-09-20 | Agilent Technologies, Inc. | Arrays with elongated features |
| US7125523B2 (en) | 2002-04-29 | 2006-10-24 | Agilent Technologies, Inc. | Holders for arrays |
| US7094537B2 (en) | 2002-04-30 | 2006-08-22 | Agilent Technologies, Inc. | Micro arrays with structured and unstructured probes |
| US6621076B1 (en) | 2002-04-30 | 2003-09-16 | Agilent Technologies, Inc. | Flexible assembly for transporting sample fluids into a mass spectrometer |
| AU2003233243A1 (en) | 2002-05-06 | 2003-11-17 | Noxxon Pharma Ag | Method for amplifying nucleic acids |
| US20030211478A1 (en) | 2002-05-08 | 2003-11-13 | Gentel Corporation | Transcription factor profiling on a solid surface |
| US7221785B2 (en) | 2002-05-21 | 2007-05-22 | Agilent Technologies, Inc. | Method and system for measuring a molecular array background signal from a continuous background region of specified size |
| AU2003241607B2 (en) | 2002-05-24 | 2007-09-06 | Nimblegen Systems, Inc. | Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| US7273730B2 (en) | 2002-05-24 | 2007-09-25 | Invitrogen Corporation | Nested PCR employing degradable primers |
| US6789965B2 (en) | 2002-05-31 | 2004-09-14 | Agilent Technologies, Inc. | Dot printer with off-axis loading |
| US7537936B2 (en) | 2002-05-31 | 2009-05-26 | Agilent Technologies, Inc. | Method of testing multiple fluid samples with multiple biopolymer arrays |
| US7078505B2 (en) | 2002-06-06 | 2006-07-18 | Agilent Technologies, Inc. | Manufacture of arrays with varying deposition parameters |
| US7919308B2 (en) | 2002-06-14 | 2011-04-05 | Agilent Technologies, Inc. | Form in place gaskets for assays |
| US7351379B2 (en) | 2002-06-14 | 2008-04-01 | Agilent Technologies, Inc. | Fluid containment structure |
| US6939673B2 (en) | 2002-06-14 | 2005-09-06 | Agilent Technologies, Inc. | Manufacture of arrays with reduced error impact |
| US7371348B2 (en) | 2002-06-14 | 2008-05-13 | Agilent Technologies | Multiple array format |
| US20070275411A1 (en) | 2006-05-25 | 2007-11-29 | Mcgall Glenn H | Silane mixtures |
| US7220573B2 (en) | 2002-06-21 | 2007-05-22 | Agilent Technologies, Inc. | Array assay devices and methods of using the same |
| US6713262B2 (en) | 2002-06-25 | 2004-03-30 | Agilent Technologies, Inc. | Methods and compositions for high throughput identification of protein/nucleic acid binding pairs |
| US7894998B2 (en) | 2002-06-26 | 2011-02-22 | Agilent Technologies, Inc. | Method for identifying suitable nucleic acid probe sequences for use in nucleic acid arrays |
| US7202358B2 (en) | 2002-07-25 | 2007-04-10 | Agilent Technologies, Inc. | Methods for producing ligand arrays |
| US7452712B2 (en) | 2002-07-30 | 2008-11-18 | Applied Biosystems Inc. | Sample block apparatus and method of maintaining a microcard on a sample block |
| US7101508B2 (en) | 2002-07-31 | 2006-09-05 | Agilent Technologies, Inc. | Chemical array fabrication errors |
| US6835938B2 (en) | 2002-07-31 | 2004-12-28 | Agilent Technologies, Inc. | Biopolymer array substrate thickness dependent automated focus-distance determination method for biopolymer array scanners |
| US7153689B2 (en) | 2002-08-01 | 2006-12-26 | Agilent Technologies, Inc. | Apparatus and methods for cleaning and priming droplet dispensing devices |
| US8946387B2 (en) | 2002-08-14 | 2015-02-03 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
| US7205128B2 (en) | 2002-08-16 | 2007-04-17 | Agilent Technologies, Inc. | Method for synthesis of the second strand of cDNA |
| US7563600B2 (en) | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
| US20040166567A1 (en) | 2002-09-26 | 2004-08-26 | Santi Daniel V | Synthetic genes |
| US7498176B2 (en) | 2002-09-27 | 2009-03-03 | Roche Nimblegen, Inc. | Microarray with hydrophobic barriers |
| CA2500936C (en) | 2002-09-30 | 2012-10-30 | Nimblegen Systems, Inc. | Parallel loading of arrays |
| WO2004031351A2 (en) | 2002-10-01 | 2004-04-15 | Nimblegen Systems, Inc. | Microarrays having multiple oligonucleotides in single array features |
| US7129075B2 (en) | 2002-10-18 | 2006-10-31 | Transgenomic, Inc. | Isolated CEL II endonuclease |
| US8283148B2 (en) | 2002-10-25 | 2012-10-09 | Agilent Technologies, Inc. | DNA polymerase compositions for quantitative PCR and methods thereof |
| WO2004039953A2 (en) | 2002-10-28 | 2004-05-13 | Xeotron Corporation | Array oligomer synthesis and use. |
| US7422911B2 (en) | 2002-10-31 | 2008-09-09 | Agilent Technologies, Inc. | Composite flexible array substrate having flexible support |
| US7364896B2 (en) | 2002-10-31 | 2008-04-29 | Agilent Technologies, Inc. | Test strips including flexible array substrates and method of hybridization |
| US7402279B2 (en) | 2002-10-31 | 2008-07-22 | Agilent Technologies, Inc. | Device with integrated microfluidic and electronic components |
| US7390457B2 (en) | 2002-10-31 | 2008-06-24 | Agilent Technologies, Inc. | Integrated microfluidic array device |
| US7629120B2 (en) | 2002-10-31 | 2009-12-08 | Rice University | Method for assembling PCR fragments of DNA |
| WO2004040295A1 (en) | 2002-10-31 | 2004-05-13 | Nanostream, Inc. | Parallel detection chromatography systems |
| US20040086892A1 (en) | 2002-11-06 | 2004-05-06 | Crothers Donald M. | Universal tag assay |
| US7029854B2 (en) | 2002-11-22 | 2006-04-18 | Agilent Technologies, Inc. | Methods designing multiple mRNA transcript nucleic acid probe sequences for use in nucleic acid arrays |
| US7062385B2 (en) | 2002-11-25 | 2006-06-13 | Tufts University | Intelligent electro-optical nucleic acid-based sensor array and method for detecting volatile compounds in ambient air |
| JP4754219B2 (ja) | 2002-12-02 | 2011-08-24 | アムジエン・フレモント・インコーポレイテツド | 腫瘍壊死因子を対象とする抗体、およびそれらの使用 |
| US20040110133A1 (en) | 2002-12-06 | 2004-06-10 | Affymetrix, Inc. | Functionated photoacid generator for biological microarray synthesis |
| US7879580B2 (en) | 2002-12-10 | 2011-02-01 | Massachusetts Institute Of Technology | Methods for high fidelity production of long nucleic acid molecules |
| US7932025B2 (en) | 2002-12-10 | 2011-04-26 | Massachusetts Institute Of Technology | Methods for high fidelity production of long nucleic acid molecules with error control |
| US20060076482A1 (en) | 2002-12-13 | 2006-04-13 | Hobbs Steven E | High throughput systems and methods for parallel sample analysis |
| US6987263B2 (en) | 2002-12-13 | 2006-01-17 | Nanostream, Inc. | High throughput systems and methods for parallel sample analysis |
| US7247337B1 (en) | 2002-12-16 | 2007-07-24 | Agilent Technologies, Inc. | Method and apparatus for microarray fabrication |
| US20040191810A1 (en) | 2002-12-17 | 2004-09-30 | Affymetrix, Inc. | Immersed microarrays in conical wells |
| GB0229443D0 (en) | 2002-12-18 | 2003-01-22 | Avecia Ltd | Process |
| US7960157B2 (en) | 2002-12-20 | 2011-06-14 | Agilent Technologies, Inc. | DNA polymerase blends and uses thereof |
| DE03808546T1 (de) | 2002-12-23 | 2006-01-26 | Agilent Technologies, Inc., Palo Alto | Vergleichende genomischehybridisierungstests unter verwendung von merkmalen immobilisierteroligonukleotide sowie zusammensetzungen zur durchführung davon |
| EP1585830A2 (de) | 2002-12-23 | 2005-10-19 | febit biotech GmbH | Photoaktivierbare zweistufige schutzgruppen für die synthese von biopolymeren |
| DE10260805A1 (de) | 2002-12-23 | 2004-07-22 | Geneart Gmbh | Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins |
| CN101899114A (zh) | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| US7372982B2 (en) | 2003-01-14 | 2008-05-13 | Agilent Technologies, Inc. | User interface for molecular array feature analysis |
| US6809277B2 (en) | 2003-01-22 | 2004-10-26 | Agilent Technologies, Inc. | Method for registering a deposited material with channel plate channels, and switch produced using same |
| CA2513535C (en) | 2003-01-29 | 2012-06-12 | 454 Corporation | Bead emulsion nucleic acid amplification |
| US7202264B2 (en) | 2003-01-31 | 2007-04-10 | Isis Pharmaceuticals, Inc. | Supports for oligomer synthesis |
| US8073626B2 (en) | 2003-01-31 | 2011-12-06 | Agilent Technologies, Inc. | Biopolymer array reading |
| US6950756B2 (en) | 2003-02-05 | 2005-09-27 | Agilent Technologies, Inc. | Rearrangement of microarray scan images to form virtual arrays |
| US7413709B2 (en) | 2003-02-12 | 2008-08-19 | Agilent Technologies, Inc. | PAEK-based microfluidic device with integrated electrospray emitter |
| GB2398383B (en) | 2003-02-12 | 2005-03-09 | Global Genomics Ab | Method and means for nucleic acid sequencing |
| US7244513B2 (en) | 2003-02-21 | 2007-07-17 | Nano-Proprietary, Inc. | Stain-etched silicon powder |
| US7252938B2 (en) | 2003-02-25 | 2007-08-07 | Agilent Technologies, Inc. | Methods and devices for producing a polymer at a location of a substrate |
| US7070932B2 (en) | 2003-02-25 | 2006-07-04 | Agilent Technologies, Inc. | Methods and devices for detecting printhead misalignment of an in situ polymeric array synthesis device |
| WO2004080887A1 (en) | 2003-03-07 | 2004-09-23 | Massachusetts Institute Of Technology | Three dimensional mecrofabrication |
| JP2004268394A (ja) | 2003-03-07 | 2004-09-30 | Canon Inc | インクジェット記録装置及びその制御方法 |
| US20050053968A1 (en) | 2003-03-31 | 2005-03-10 | Council Of Scientific And Industrial Research | Method for storing information in DNA |
| US7534561B2 (en) | 2003-04-02 | 2009-05-19 | Agilent Technologies, Inc. | Nucleic acid array in situ fabrication methods and arrays produced using the same |
| EP1613776A1 (en) | 2003-04-02 | 2006-01-11 | Blue Heron Biotechnology, Inc. | Error reduction in automated gene synthesis |
| US7206439B2 (en) | 2003-04-30 | 2007-04-17 | Agilent Technologies, Inc. | Feature locations in array reading |
| US7269518B2 (en) | 2003-04-30 | 2007-09-11 | Agilent Technologies, Inc. | Chemical array reading |
| US20040219663A1 (en) | 2003-04-30 | 2004-11-04 | Page Robert D. | Biopolymer array fabrication using different drop deposition heads |
| US6916113B2 (en) | 2003-05-16 | 2005-07-12 | Agilent Technologies, Inc. | Devices and methods for fluid mixing |
| US7695683B2 (en) | 2003-05-20 | 2010-04-13 | Fluidigm Corporation | Method and system for microfluidic device and imaging thereof |
| EP1633889B1 (en) | 2003-05-30 | 2010-09-01 | The Board Of Trustees Of The University Of Illinois | Gene expression profiles that identify genetically elite ungulate mammals |
| US7276599B2 (en) | 2003-06-02 | 2007-10-02 | Isis Pharmaceuticals, Inc. | Oligonucleotide synthesis with alternative solvents |
| US8133670B2 (en) | 2003-06-13 | 2012-03-13 | Cold Spring Harbor Laboratory | Method for making populations of defined nucleic acid molecules |
| US6938476B2 (en) | 2003-06-25 | 2005-09-06 | Agilent Technologies, Inc. | Apparatus and methods for sensing fluid levels |
| US7534563B2 (en) | 2003-06-30 | 2009-05-19 | Agilent Technologies, Inc. | Methods for producing ligand arrays |
| US20050016851A1 (en) | 2003-07-24 | 2005-01-27 | Jensen Klavs F. | Microchemical method and apparatus for synthesis and coating of colloidal nanoparticles |
| US6843281B1 (en) | 2003-07-30 | 2005-01-18 | Agilent Techinologies, Inc. | Methods and apparatus for introducing liquids into microfluidic chambers |
| US7353116B2 (en) | 2003-07-31 | 2008-04-01 | Agilent Technologies, Inc. | Chemical array with test dependent signal reading or processing |
| WO2005014850A2 (en) | 2003-08-06 | 2005-02-17 | University Of Massachusetts | Systems and methods for analyzing nucleic acid sequences |
| US7028536B2 (en) | 2004-06-29 | 2006-04-18 | Nanostream, Inc. | Sealing interface for microfluidic device |
| US7348144B2 (en) | 2003-08-13 | 2008-03-25 | Agilent Technologies, Inc. | Methods and system for multi-drug treatment discovery |
| US7229497B2 (en) | 2003-08-26 | 2007-06-12 | Massachusetts Institute Of Technology | Method of preparing nanocrystals |
| US7585970B2 (en) | 2003-08-30 | 2009-09-08 | Agilent Technologies, Inc. | Method of polynucleotide synthesis using modified support |
| US7427679B2 (en) | 2003-08-30 | 2008-09-23 | Agilent Technologies, Inc. | Precursors for two-step polynucleotide synthesis |
| US7193077B2 (en) | 2003-08-30 | 2007-03-20 | Agilent Technologies, Inc. | Exocyclic amine triaryl methyl protecting groups in two-step polynucleotide synthesis |
| US7385050B2 (en) | 2003-08-30 | 2008-06-10 | Agilent Technologies, Inc. | Cleavable linker for polynucleotide synthesis |
| US7417139B2 (en) | 2003-08-30 | 2008-08-26 | Agilent Technologies, Inc. | Method for polynucleotide synthesis |
| US20050049796A1 (en) | 2003-09-03 | 2005-03-03 | Webb Peter G. | Methods for encoding non-biological information on microarrays |
| WO2005023993A2 (en) | 2003-09-09 | 2005-03-17 | Integrigen, Inc. | Methods and compositions for generation of germline human antibody genes |
| JP2007506429A (ja) | 2003-09-23 | 2007-03-22 | アトム・サイエンシズ・インコーポレーテッド | ポリマー核酸のハイブリダイゼーションプローブ |
| US7488607B2 (en) | 2003-09-30 | 2009-02-10 | Agilent Technologies, Inc. | Electronically readable microarray with electronic addressing function |
| US7147362B2 (en) | 2003-10-15 | 2006-12-12 | Agilent Technologies, Inc. | Method of mixing by intermittent centrifugal force |
| US7075161B2 (en) | 2003-10-23 | 2006-07-11 | Agilent Technologies, Inc. | Apparatus and method for making a low capacitance artificial nanopore |
| US20050277125A1 (en) | 2003-10-27 | 2005-12-15 | Massachusetts Institute Of Technology | High-density reaction chambers and methods of use |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US7276338B2 (en) | 2003-11-17 | 2007-10-02 | Jacobson Joseph M | Nucleotide sequencing via repetitive single molecule hybridization |
| DE10353887A1 (de) | 2003-11-18 | 2005-06-16 | Febit Ag | Hochparalleler DNA-Synthesizer auf Matrizenbasis |
| US7851192B2 (en) | 2004-11-22 | 2010-12-14 | New England Biolabs, Inc. | Modified DNA cleavage enzymes and methods for use |
| US8802418B2 (en) | 2010-04-09 | 2014-08-12 | The Catholic University Of America | Protein and nucleic acid delivery vehicles, components and mechanisms thereof |
| US7282705B2 (en) | 2003-12-19 | 2007-10-16 | Agilent Technologies, Inc. | Microdevice having an annular lining for producing an electrospray emitter |
| JP2007525571A (ja) | 2004-01-07 | 2007-09-06 | ソレクサ リミテッド | 修飾分子アレイ |
| EP1735458B1 (en) | 2004-01-28 | 2013-07-24 | 454 Life Sciences Corporation | Nucleic acid amplification with continuous flow emulsion |
| US7084180B2 (en) | 2004-01-28 | 2006-08-01 | Velocys, Inc. | Fischer-tropsch synthesis using microchannel technology and novel catalyst and microchannel reactor |
| US7125488B2 (en) | 2004-02-12 | 2006-10-24 | Varian, Inc. | Polar-modified bonded phase materials for chromatographic separations |
| EP1713936B1 (en) | 2004-02-12 | 2009-12-09 | Population Genetics Technologies Ltd Corporation of Great Britain | Genetic analysis by sequence-specific sorting |
| CA2558749A1 (en) | 2004-02-27 | 2005-09-29 | President And Fellows Of Harvard College | Polynucleotide synthesis |
| WO2005093092A2 (en) | 2004-03-26 | 2005-10-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) |
| US7875463B2 (en) | 2004-03-26 | 2011-01-25 | Agilent Technologies, Inc. | Generalized pulse jet ejection head control model |
| US20050214779A1 (en) | 2004-03-29 | 2005-09-29 | Peck Bill J | Methods for in situ generation of nucleic acid arrays |
| US20050214778A1 (en) | 2004-03-29 | 2005-09-29 | Peck Bill J | Methods for in situ generation of nucleic acid arrays |
| US8825411B2 (en) | 2004-05-04 | 2014-09-02 | Dna Twopointo, Inc. | Design, synthesis and assembly of synthetic nucleic acids |
| WO2005111246A1 (en) | 2004-05-11 | 2005-11-24 | Wyeth | Oligonucleotide arrays to monitor gene expression and methods for making and using same |
| JP2007537759A (ja) | 2004-05-19 | 2007-12-27 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 灌流三次元細胞/組織疾患モデル |
| US7302348B2 (en) | 2004-06-02 | 2007-11-27 | Agilent Technologies, Inc. | Method and system for quantifying and removing spatial-intensity trends in microarray data |
| US20060024711A1 (en) | 2004-07-02 | 2006-02-02 | Helicos Biosciences Corporation | Methods for nucleic acid amplification and sequence determination |
| US9012369B2 (en) | 2004-07-06 | 2015-04-21 | Pfizer Inc. | Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| US20060012793A1 (en) | 2004-07-19 | 2006-01-19 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
| US7276720B2 (en) | 2004-07-19 | 2007-10-02 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
| US20060019084A1 (en) | 2004-07-23 | 2006-01-26 | Pearson Laurence T | Monolithic composition and method |
| US20060024678A1 (en) | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
| DK1776460T3 (da) | 2004-08-03 | 2010-04-12 | Geneart Ag | Fremgangsmåde til modulering af genekspression ved ændring af CpG-indholdet |
| WO2006073504A2 (en) | 2004-08-04 | 2006-07-13 | President And Fellows Of Harvard College | Wobble sequencing |
| WO2006018044A1 (en) | 2004-08-18 | 2006-02-23 | Agilent Technologies, Inc. | Microfluidic assembly with coupled microfluidic devices |
| US7034290B2 (en) | 2004-09-24 | 2006-04-25 | Agilent Technologies, Inc. | Target support with pattern recognition sites |
| US7943046B2 (en) | 2004-10-01 | 2011-05-17 | Agilent Technologies, Inc | Methods and systems for on-column protein delipidation |
| US20070122817A1 (en) | 2005-02-28 | 2007-05-31 | George Church | Methods for assembly of high fidelity synthetic polynucleotides |
| AU2005295351A1 (en) * | 2004-10-18 | 2006-04-27 | Codon Devices, Inc. | Methods for assembly of high fidelity synthetic polynucleotides |
| US7141807B2 (en) | 2004-10-22 | 2006-11-28 | Agilent Technologies, Inc. | Nanowire capillaries for mass spectrometry |
| US20060110744A1 (en) | 2004-11-23 | 2006-05-25 | Sampas Nicolas M | Probe design methods and microarrays for comparative genomic hybridization and location analysis |
| US8380441B2 (en) | 2004-11-30 | 2013-02-19 | Agilent Technologies, Inc. | Systems for producing chemical array layouts |
| US7977119B2 (en) | 2004-12-08 | 2011-07-12 | Agilent Technologies, Inc. | Chemical arrays and methods of using the same |
| US11268149B2 (en) | 2004-12-08 | 2022-03-08 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease |
| US7439272B2 (en) | 2004-12-20 | 2008-10-21 | Varian, Inc. | Ultraporous sol gel monoliths |
| US20090285825A1 (en) | 2004-12-22 | 2009-11-19 | National University Of Singapore | Novel snake toxin |
| US20070099196A1 (en) | 2004-12-29 | 2007-05-03 | Sakari Kauppinen | Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs |
| AU2006204697A1 (en) * | 2005-01-13 | 2006-07-20 | Codon Devices, Inc. | Compositions and methods for protein design |
| US20060171855A1 (en) | 2005-02-03 | 2006-08-03 | Hongfeng Yin | Devices,systems and methods for multi-dimensional separation |
| WO2006086391A2 (en) | 2005-02-07 | 2006-08-17 | Massachusetts Institute Of Technology | Electrochemically-degradable layer-by-layer thin films |
| US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
| JP4641199B2 (ja) | 2005-02-28 | 2011-03-02 | 国立感染症研究所長 | Rna干渉ポリヌクレオチド混合物の設計装置、rna干渉ポリヌクレオチド混合物の作製方法、及びrna干渉ポリヌクレオチド混合物の設計プログラム |
| US20060203236A1 (en) | 2005-03-08 | 2006-09-14 | Zhenghua Ji | Sample cell |
| WO2007086890A2 (en) | 2005-03-10 | 2007-08-02 | Genemark Inc. | Method, apparatus, and system for authentication using labels containing nucleotide seouences |
| EP1623763A1 (en) | 2005-03-11 | 2006-02-08 | Agilent Technologies, Inc. | Chip with cleaning cavity |
| US7618777B2 (en) | 2005-03-16 | 2009-11-17 | Agilent Technologies, Inc. | Composition and method for array hybridization |
| US20060219637A1 (en) | 2005-03-29 | 2006-10-05 | Killeen Kevin P | Devices, systems and methods for liquid chromatography |
| EP1874792B1 (en) | 2005-04-27 | 2016-04-13 | Sigma-Aldrich Co. LLC | Activators for oligonucleotide and phosphoramidite synthesis |
| US7572907B2 (en) | 2005-04-29 | 2009-08-11 | Agilent Technologies, Inc. | Methods and compounds for polynucleotide synthesis |
| DK1885880T3 (da) | 2005-04-29 | 2010-11-08 | Synthetic Genomics Inc | Amplifikation og kloning af enkelte DNA-molekyler ved anvendelse af rolling circle-amplifikation |
| ATE448280T1 (de) | 2005-05-12 | 2009-11-15 | Hempel As | Verfahren zur herstellung einer rissfesten epoxidlackschicht und dafür geeignete lacke |
| US7396676B2 (en) | 2005-05-31 | 2008-07-08 | Agilent Technologies, Inc. | Evanescent wave sensor with attached ligand |
| EP1907571B1 (en) | 2005-06-15 | 2017-04-26 | Complete Genomics Inc. | Nucleic acid analysis by random mixtures of non-overlapping fragments |
| US7919239B2 (en) | 2005-07-01 | 2011-04-05 | Agilent Technologies, Inc. | Increasing hybridization efficiencies |
| US8076064B2 (en) | 2005-07-09 | 2011-12-13 | Agilent Technologies, Inc. | Method of treatment of RNA sample |
| US7718365B2 (en) | 2005-07-09 | 2010-05-18 | Agilent Technologies, Inc. | Microarray analysis of RNA |
| EP1924704B1 (en) | 2005-08-02 | 2011-05-25 | Rubicon Genomics, Inc. | Compositions and methods for processing and amplification of dna, including using multiple enzymes in a single reaction |
| DE102005037351B3 (de) | 2005-08-08 | 2007-01-11 | Geneart Ag | Verfahren für die kontinuierliche zielgerichtete Evolution von Proteinen in vitro |
| DK1915446T3 (en) | 2005-08-11 | 2017-09-11 | Synthetic Genomics Inc | IN VITRO RECOMBINATION PROCEDURE |
| US7749701B2 (en) | 2005-08-11 | 2010-07-06 | Agilent Technologies, Inc. | Controlling use of oligonucleotide sequences released from arrays |
| US9404882B2 (en) | 2005-08-11 | 2016-08-02 | New Mexico Tech Research Foundation | Method of producing a multi-microchannel, flow-through element and device using same |
| DK1929012T3 (da) | 2005-08-11 | 2011-01-31 | Synthetic Genomics Inc | Fremgangsmåde til in vitro-rekombination |
| US7805252B2 (en) | 2005-08-16 | 2010-09-28 | Dna Twopointo, Inc. | Systems and methods for designing and ordering polynucleotides |
| WO2007025059A1 (en) | 2005-08-26 | 2007-03-01 | Surmodics, Inc. | Silane coating compositions, coating systems, and methods |
| US20070196834A1 (en) | 2005-09-09 | 2007-08-23 | Francesco Cerrina | Method and system for the generation of large double stranded DNA fragments |
| WO2007033176A2 (en) | 2005-09-14 | 2007-03-22 | Illumina, Inc. | Continuous polymer synthesizer |
| US20100233429A1 (en) | 2005-09-16 | 2010-09-16 | Yamatake Corporation | Substrate for Biochip, Biochip, Method for Manufacturing Substrate for Biochip and Method for Manufacturing Biochip |
| US20080308884A1 (en) | 2005-10-13 | 2008-12-18 | Silex Microsystems Ab | Fabrication of Inlet and Outlet Connections for Microfluidic Chips |
| US8202985B2 (en) | 2005-10-31 | 2012-06-19 | Agilent Technologies, Inc. | Monomer compositions for the synthesis of polynucleotides, methods of synthesis, and methods of deprotection |
| US8552174B2 (en) | 2005-10-31 | 2013-10-08 | Agilent Technologies, Inc. | Solutions, methods, and processes for deprotection of polynucleotides |
| US7368550B2 (en) | 2005-10-31 | 2008-05-06 | Agilent Technologies, Inc. | Phosphorus protecting groups |
| US7759471B2 (en) | 2005-10-31 | 2010-07-20 | Agilent Technologies, Inc. | Monomer compositions for the synthesis of RNA, methods of synthesis, and methods of deprotection |
| GB0522310D0 (en) | 2005-11-01 | 2005-12-07 | Solexa Ltd | Methods of preparing libraries of template polynucleotides |
| US7291471B2 (en) | 2005-11-21 | 2007-11-06 | Agilent Technologies, Inc. | Cleavable oligonucleotide arrays |
| GB0524069D0 (en) | 2005-11-25 | 2006-01-04 | Solexa Ltd | Preparation of templates for solid phase amplification |
| US8137936B2 (en) | 2005-11-29 | 2012-03-20 | Macevicz Stephen C | Selected amplification of polynucleotides |
| CN101365803B (zh) | 2005-12-22 | 2013-03-20 | 关键基因股份有限公司 | 采用高通量测序技术的改进的转录谱描述策略 |
| US7939645B2 (en) | 2006-01-06 | 2011-05-10 | Agilent Technologies, Inc | Reaction buffer composition for nucleic acid replication with packed DNA polymerases |
| EP3913375A1 (en) | 2006-01-11 | 2021-11-24 | Bio-Rad Laboratories, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
| US7544473B2 (en) | 2006-01-23 | 2009-06-09 | Population Genetics Technologies Ltd. | Nucleic acid analysis using sequence tokens |
| WO2007087377A2 (en) | 2006-01-25 | 2007-08-02 | Massachusetts Institute Of Technology | Photoelectrochemical synthesis of high density combinatorial polymer arrays |
| US9274108B2 (en) | 2006-02-06 | 2016-03-01 | Massachusetts Institute Of Technology | Self-assembly of macromolecules on multilayered polymer surfaces |
| WO2007095171A2 (en) | 2006-02-14 | 2007-08-23 | Massachusetts Institute Of Technology | Absorbing film |
| US7807356B2 (en) | 2006-03-09 | 2010-10-05 | Agilent Technologies, Inc. | Labeled nucleotide composition |
| TW200806317A (en) | 2006-03-20 | 2008-02-01 | Wyeth Corp | Methods for reducing protein aggregation |
| US7572908B2 (en) | 2006-03-23 | 2009-08-11 | Agilent Technologies, Inc. | Cleavable linkers for polynucleotides |
| US7855281B2 (en) | 2006-03-23 | 2010-12-21 | Agilent Technologies, Inc. | Cleavable thiocarbonate linkers for polynucleotide synthesis |
| US20070231800A1 (en) | 2006-03-28 | 2007-10-04 | Agilent Technologies, Inc. | Determination of methylated DNA |
| SG170802A1 (en) | 2006-03-31 | 2011-05-30 | Solexa Inc | Systems and devices for sequence by synthesis analysis |
| US20070238108A1 (en) | 2006-04-07 | 2007-10-11 | Agilent Technologies, Inc. | Validation of comparative genomic hybridization |
| US20070238104A1 (en) | 2006-04-07 | 2007-10-11 | Agilent Technologies, Inc. | Competitive oligonucleotides |
| US20070238106A1 (en) | 2006-04-07 | 2007-10-11 | Agilent Technologies, Inc. | Systems and methods of determining alleles and/or copy numbers |
| MX2008012754A (es) | 2006-04-07 | 2009-04-27 | Us Gov Health & Human Serv | Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica. |
| US8058055B2 (en) | 2006-04-07 | 2011-11-15 | Agilent Technologies, Inc. | High resolution chromosomal mapping |
| US20100173364A1 (en) | 2006-04-11 | 2010-07-08 | New England Biolabs, Inc. | Repair of Nucleic Acids for Improved Amplification |
| AU2007237909A1 (en) | 2006-04-19 | 2007-10-25 | Applied Biosystems, Llc. | Reagents, methods, and libraries for gel-free bead-based sequencing |
| US8383338B2 (en) | 2006-04-24 | 2013-02-26 | Roche Nimblegen, Inc. | Methods and systems for uniform enrichment of genomic regions |
| US20070259347A1 (en) | 2006-05-03 | 2007-11-08 | Agilent Technologies, Inc. | Methods of increasing the effective probe densities of arrays |
| US20070259345A1 (en) | 2006-05-03 | 2007-11-08 | Agilent Technologies, Inc. | Target determination using compound probes |
| US20070259344A1 (en) | 2006-05-03 | 2007-11-08 | Agilent Technologies, Inc. | Compound probes and methods of increasing the effective probe densities of arrays |
| US20070259346A1 (en) | 2006-05-03 | 2007-11-08 | Agilent Technologies, Inc. | Analysis of arrays |
| US20070281309A1 (en) | 2006-05-19 | 2007-12-06 | Massachusetts Institute Of Technology | Microfluidic-based Gene Synthesis |
| WO2007136834A2 (en) | 2006-05-19 | 2007-11-29 | Codon Devices, Inc. | Combined extension and ligation for nucleic acid assembly |
| WO2008054543A2 (en) | 2006-05-20 | 2008-05-08 | Codon Devices, Inc. | Oligonucleotides for multiplex nucleic acid assembly |
| US8962532B2 (en) | 2006-06-19 | 2015-02-24 | Yeda Research And Development Co. Ltd. | Programmable iterated elongation: a method for manufacturing synthetic genes and combinatorial DNA and protein libraries |
| AT503861B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von t-zell-rezeptoren |
| AT503902B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
| US20080193772A1 (en) | 2006-07-07 | 2008-08-14 | Bio-Rad Laboratories, Inc | Mass spectrometry probes having hydrophobic coatiings |
| US7524942B2 (en) | 2006-07-31 | 2009-04-28 | Agilent Technologies, Inc. | Labeled nucleotide composition |
| US7572585B2 (en) | 2006-07-31 | 2009-08-11 | Agilent Technologies, Inc. | Enzymatic labeling of RNA |
| WO2008015396A2 (en) | 2006-07-31 | 2008-02-07 | Solexa Limited | Method of library preparation avoiding the formation of adaptor dimers |
| HUE037173T2 (hu) | 2006-08-08 | 2018-08-28 | Univ Bonn Rheinische Friedrich Wilhelms | 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása |
| DE102006039479A1 (de) | 2006-08-23 | 2008-03-06 | Febit Biotech Gmbh | Programmierbare Oligonukleotidsynthese |
| WO2008023179A2 (en) | 2006-08-24 | 2008-02-28 | Solexa Limited | Method for retaining even coverage of short insert libraries |
| WO2008027558A2 (en) | 2006-08-31 | 2008-03-06 | Codon Devices, Inc. | Iterative nucleic acid assembly using activation of vector-encoded traits |
| US8415138B2 (en) | 2006-08-31 | 2013-04-09 | Agilent Technologies, Inc. | Apparatuses and methods for oligonucleotide preparation |
| US8097711B2 (en) | 2006-09-02 | 2012-01-17 | Agilent Technologies, Inc. | Thioether substituted aryl carbonate protecting groups |
| US20080311628A1 (en) | 2006-10-03 | 2008-12-18 | Ghc Technologies, Inc. | Methods and compositions for rapid amplification and capture of nucleic acid sequences |
| US20080287320A1 (en) | 2006-10-04 | 2008-11-20 | Codon Devices | Libraries and their design and assembly |
| US20080085511A1 (en) | 2006-10-05 | 2008-04-10 | Peck Bill J | Preparation of biopolymer arrays |
| US20080085514A1 (en) | 2006-10-10 | 2008-04-10 | Peck Bill J | Methods and devices for array synthesis |
| JP2008097189A (ja) | 2006-10-10 | 2008-04-24 | National Institute Of Advanced Industrial & Technology | 塩基配列断片の転写物特異性又は遺伝子特異性を判定する方法 |
| US7867782B2 (en) | 2006-10-19 | 2011-01-11 | Agilent Technologies, Inc. | Nanoscale moiety placement methods |
| US7999087B2 (en) | 2006-11-15 | 2011-08-16 | Agilent Technologies, Inc. | 2′-silyl containing thiocarbonate protecting groups for RNA synthesis |
| WO2008063134A1 (en) | 2006-11-24 | 2008-05-29 | Agency For Science, Technology And Research | Method of producing a pattern of discriminative wettability |
| WO2008063135A1 (en) | 2006-11-24 | 2008-05-29 | Agency For Science, Technology And Research | Apparatus for processing a sample in a liquid droplet and method of using the same |
| US8242258B2 (en) | 2006-12-03 | 2012-08-14 | Agilent Technologies, Inc. | Protecting groups for RNA synthesis |
| JP2010511397A (ja) | 2006-12-05 | 2010-04-15 | アブリンクス エン.ヴェー. | 血清タンパク質と結合可能なペプチド |
| US7989396B2 (en) | 2006-12-05 | 2011-08-02 | The Board Of Trustees Of The Leland Stanford Junior University | Biomolecule immobilization on biosensors |
| US7862999B2 (en) | 2007-01-17 | 2011-01-04 | Affymetrix, Inc. | Multiplex targeted amplification using flap nuclease |
| US8314220B2 (en) | 2007-01-26 | 2012-11-20 | Agilent Technologies, Inc. | Methods compositions, and kits for detection of microRNA |
| US20080182296A1 (en) | 2007-01-31 | 2008-07-31 | Chanda Pranab K | Pcr-directed gene synthesis from large number of overlapping oligodeoxyribonucleotides |
| KR100827449B1 (ko) | 2007-02-07 | 2008-05-07 | 삼성전자주식회사 | 광분해성 화합물과 상기 화합물이 커플링된 올리고머프로브 어레이용 기판, 올리고머 프로브 어레이 및 이의제조 방법 |
| US20100323404A1 (en) | 2007-02-09 | 2010-12-23 | Richard Lathrop | Method for recombining dna sequences and compositions related thereto |
| JP2010520748A (ja) | 2007-02-20 | 2010-06-17 | アナプティスバイオ インコーポレイティッド | 体細胞超変異系 |
| WO2008109176A2 (en) | 2007-03-07 | 2008-09-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
| US7651762B2 (en) | 2007-03-13 | 2010-01-26 | Varian, Inc. | Methods and devices using a shrinkable support for porous monolithic materials |
| AU2008236694B2 (en) | 2007-04-04 | 2014-01-23 | The Regents Of The University Of California | Compositions, devices, systems, and methods for using a nanopore |
| WO2008141248A2 (en) | 2007-05-10 | 2008-11-20 | Agilent Technologies, Inc. | Thiocarbon-protecting groups for rna synthesis |
| US20100286290A1 (en) | 2007-06-04 | 2010-11-11 | Jakob Schwalbe Lohmann | Enzyme activity assay using rolling circle amplification |
| US20090023190A1 (en) | 2007-06-20 | 2009-01-22 | Kai Qin Lao | Sequence amplification with loopable primers |
| US20080318334A1 (en) | 2007-06-20 | 2008-12-25 | Robotti Karla M | Microfluidic devices comprising fluid flow paths having a monolithic chromatographic material |
| US8194244B2 (en) | 2007-06-29 | 2012-06-05 | Intel Corporation | Solution sample plate with wells designed for improved Raman scattering signal detection efficiency |
| US7659069B2 (en) | 2007-08-31 | 2010-02-09 | Agilent Technologies, Inc. | Binary signaling assay using a split-polymerase |
| US7979215B2 (en) | 2007-07-30 | 2011-07-12 | Agilent Technologies, Inc. | Methods and systems for evaluating CGH candidate probe nucleic acid sequences |
| US8685642B2 (en) | 2007-07-30 | 2014-04-01 | Agilent Technologies, Inc. | Allele-specific copy number measurement using single nucleotide polymorphism and DNA arrays |
| US20090036664A1 (en) | 2007-07-31 | 2009-02-05 | Brian Jon Peter | Complex oligonucleotide primer mix |
| JP2010535502A (ja) | 2007-08-07 | 2010-11-25 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 遺伝子合成のための一体型マイクロ流体デバイス |
| US9440231B2 (en) | 2007-08-14 | 2016-09-13 | Fluidigm Corporation | Polymer microfluidic biochip fabrication |
| US20110126929A1 (en) | 2007-08-15 | 2011-06-02 | Massachusetts Institute Of Technology | Microstructures For Fluidic Ballasting and Flow Control |
| US20090053704A1 (en) | 2007-08-24 | 2009-02-26 | Natalia Novoradovskaya | Stabilization of nucleic acids on solid supports |
| US9598737B2 (en) | 2012-05-09 | 2017-03-21 | Longhorn Vaccines And Diagnostics, Llc | Next generation genomic sequencing methods |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| EP2198000A4 (en) | 2007-09-17 | 2013-02-20 | SUPRAMOLECULAR NANO-STAMP PRINTING DEVICE | |
| US7790387B2 (en) | 2007-09-24 | 2010-09-07 | Agilent Technologies, Inc. | Thiocarbonate linkers for polynucleotides |
| AU2008307617B2 (en) | 2007-09-28 | 2013-05-23 | Pacific Biosciences Of California, Inc. | Error-free amplification of DNA for clonal sequencing |
| EP2053132A1 (en) | 2007-10-23 | 2009-04-29 | Roche Diagnostics GmbH | Enrichment and sequence analysis of geomic regions |
| WO2009070665A1 (en) | 2007-11-27 | 2009-06-04 | Massachusetts Institute Of Technology | Near field detector for integrated surface plasmon resonance biosensor applications |
| US20100272711A1 (en) | 2007-12-12 | 2010-10-28 | Thomas Jefferson University | Compositions and methods for the treatment and prevention of cardiovascular diseases |
| US9286439B2 (en) | 2007-12-17 | 2016-03-15 | Yeda Research And Development Co Ltd | System and method for editing and manipulating DNA |
| WO2012044847A1 (en) | 2010-10-01 | 2012-04-05 | Life Technologies Corporation | Nucleic acid adaptors and uses thereof |
| EP2235217B1 (en) | 2008-01-09 | 2016-04-20 | Life Technologies Corporation | Method of making a paired tag library for nucleic acid sequencing |
| US7682809B2 (en) | 2008-01-11 | 2010-03-23 | Agilent Technologies, Inc. | Direct ATP release sequencing |
| EP2238459B1 (en) | 2008-01-23 | 2019-05-08 | Roche Diagnostics GmbH | Integrated instrument performing synthesis and amplification |
| US8304273B2 (en) | 2008-01-24 | 2012-11-06 | Massachusetts Institute Of Technology | Insulated nanogap devices and methods of use thereof |
| WO2009097368A2 (en) | 2008-01-28 | 2009-08-06 | Complete Genomics, Inc. | Methods and compositions for efficient base calling in sequencing reactions |
| US20090194483A1 (en) | 2008-01-31 | 2009-08-06 | Robotti Karla M | Microfluidic device having monolithic separation medium and method of use |
| DK2255013T3 (en) | 2008-02-15 | 2016-09-12 | Synthetic Genomics Inc | Methods for in vitro joining and combinatorial assembly of nucleic acid molecules. |
| US20110009607A1 (en) | 2008-03-11 | 2011-01-13 | Makoto Komiyama | Method for preparing dna fragment having sticky end |
| US20090230044A1 (en) | 2008-03-13 | 2009-09-17 | Agilent Technologies, Inc. | Microfluid Chip Cleaning |
| US20090238722A1 (en) | 2008-03-18 | 2009-09-24 | Agilent Technologies, Inc. | Pressure-Reinforced Fluidic Chip |
| WO2009145818A1 (en) | 2008-03-31 | 2009-12-03 | Pacific Biosciences Of California, Inc | Single molecule loading methods and compositions |
| US20090246788A1 (en) | 2008-04-01 | 2009-10-01 | Roche Nimblegen, Inc. | Methods and Assays for Capture of Nucleic Acids |
| WO2009126290A2 (en) | 2008-04-09 | 2009-10-15 | Cornell University | Coferons and methods of making and using them |
| US8911948B2 (en) | 2008-04-30 | 2014-12-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
| JP4582224B2 (ja) | 2008-05-02 | 2010-11-17 | ソニー株式会社 | マイクロビーズ作製方法及びマイクロビーズ |
| EP2113255A1 (en) * | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| WO2009147537A2 (en) | 2008-05-27 | 2009-12-10 | Dako Denmark A/S | Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers |
| EP2310416A1 (en) | 2008-06-30 | 2011-04-20 | Morphotek, Inc. | Anti-gd2 antibodies and methods and uses related thereto |
| GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| JP4667490B2 (ja) | 2008-07-09 | 2011-04-13 | 三菱電機株式会社 | 加熱調理器 |
| WO2010014903A1 (en) | 2008-07-31 | 2010-02-04 | Massachusetts Institute Of Technology | Multiplexed olfactory receptor-based microsurface plasmon polariton detector |
| US20100069250A1 (en) | 2008-08-16 | 2010-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Digital PCR Calibration for High Throughput Sequencing |
| KR20160015400A (ko) | 2008-08-22 | 2016-02-12 | 상가모 바이오사이언스 인코포레이티드 | 표적화된 단일가닥 분할 및 표적화된 통합을 위한 방법 및 조성물 |
| US8808986B2 (en) | 2008-08-27 | 2014-08-19 | Gen9, Inc. | Methods and devices for high fidelity polynucleotide synthesis |
| US8034917B2 (en) | 2008-08-28 | 2011-10-11 | Agilent Technologies, Inc. | Primer-directed chromosome painting |
| WO2010028366A2 (en) | 2008-09-05 | 2010-03-11 | Life Technologies Corporation | Methods and systems for nucleic acid sequencing validation, calibration and normalization |
| US9249175B2 (en) | 2008-09-05 | 2016-02-02 | The Royal Institute For The Advancement Of Learning/Mcgill University | RNA monomers containing O-acetal levulinyl ester groups and their use in RNA microarrays |
| US8586310B2 (en) | 2008-09-05 | 2013-11-19 | Washington University | Method for multiplexed nucleic acid patch polymerase chain reaction |
| US8309707B2 (en) | 2008-09-06 | 2012-11-13 | Chemgenes Corporation | RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end |
| US8541569B2 (en) | 2008-09-06 | 2013-09-24 | Chemgenes Corporation | Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA |
| US20100062495A1 (en) | 2008-09-10 | 2010-03-11 | Genscript Corporation | Homologous recombination-based DNA cloning methods and compositions |
| US20100076183A1 (en) | 2008-09-22 | 2010-03-25 | Dellinger Douglas J | Protected monomer and method of final deprotection for rna synthesis |
| US8213015B2 (en) | 2008-09-25 | 2012-07-03 | Agilent Technologies, Inc. | Integrated flow cell with semiconductor oxide tubing |
| US8404445B2 (en) | 2008-09-30 | 2013-03-26 | Abbvie Inc. | Antibody libraries |
| US20100090341A1 (en) | 2008-10-14 | 2010-04-15 | Molecular Imprints, Inc. | Nano-patterned active layers formed by nano-imprint lithography |
| US20100301398A1 (en) | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
| US9080211B2 (en) | 2008-10-24 | 2015-07-14 | Epicentre Technologies Corporation | Transposon end compositions and methods for modifying nucleic acids |
| JP2012507513A (ja) | 2008-11-06 | 2012-03-29 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | バイオポリマー合成用器具 |
| US8357489B2 (en) | 2008-11-13 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for detecting hepatocellular carcinoma |
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| RU2015151857A (ru) | 2008-12-02 | 2019-01-15 | Уэйв Лайф Сайенсес Джапан, Инк. | Способ синтеза модифицированных по атому фосфора нуклеиновых кислот |
| US8963262B2 (en) | 2009-08-07 | 2015-02-24 | Massachusettes Institute Of Technology | Method and apparatus for forming MEMS device |
| JO3382B1 (ar) | 2008-12-23 | 2019-03-13 | Amgen Inc | أجسام مضادة ترتبط مع مستقبل cgrp بشري |
| TW201104253A (en) | 2008-12-31 | 2011-02-01 | Nat Health Research Institutes | Microarray chip and method of fabricating for the same |
| CA2751762A1 (en) | 2009-02-09 | 2010-08-12 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit U Nd Umwelt (Gmbh) | Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof |
| US8569046B2 (en) | 2009-02-20 | 2013-10-29 | Massachusetts Institute Of Technology | Microarray with microchannels |
| US20100216648A1 (en) | 2009-02-20 | 2010-08-26 | Febit Holding Gmbh | Synthesis of sequence-verified nucleic acids |
| ES2661310T3 (es) * | 2009-03-09 | 2018-03-28 | Bioatla, Llc | Proteínas mirac |
| US8709717B2 (en) | 2009-04-03 | 2014-04-29 | Illumina, Inc. | Generation of uniform fragments of nucleic acids using patterned substrates |
| JP2010248084A (ja) | 2009-04-10 | 2010-11-04 | Invitrogen Japan Kk | 新規洗浄溶媒を用いるオリゴヌクレオチド合成法 |
| US7862716B2 (en) | 2009-04-13 | 2011-01-04 | Sielc Technologies Corporation | HPLC schematic with integrated sample cleaning system |
| WO2010124734A1 (en) | 2009-04-29 | 2010-11-04 | Telecom Italia S.P.A. | Method and apparatus for depositing a biological fluid onto a substrate |
| US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
| EP2248914A1 (en) | 2009-05-05 | 2010-11-10 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | The use of class IIB restriction endonucleases in 2nd generation sequencing applications |
| US9309557B2 (en) | 2010-12-17 | 2016-04-12 | Life Technologies Corporation | Nucleic acid amplification |
| US20100292102A1 (en) | 2009-05-14 | 2010-11-18 | Ali Nouri | System and Method For Preventing Synthesis of Dangerous Biological Sequences |
| US20100300882A1 (en) | 2009-05-26 | 2010-12-02 | General Electric Company | Devices and methods for in-line sample preparation of materials |
| ES2532891T3 (es) | 2009-06-02 | 2015-04-01 | The Regents Of The University Of California | Descubrimiento de virus mediante secuenciación y ensamblaje de ARNip, miARN, ARNpi derivados de virus |
| WO2010141249A2 (en) | 2009-06-02 | 2010-12-09 | Merck Sharp & Dohme Corp. | Generation, characterization and uses thereof of anti-notch3 antibodies |
| US8309710B2 (en) | 2009-06-29 | 2012-11-13 | Agilent Technologies, Inc. | Use of N-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide |
| US8642755B2 (en) | 2009-06-30 | 2014-02-04 | Agilent Technologies, Inc. | Use of thioacetic acid derivatives in the sulfurization of oligonucleotides with phenylacetyl disulfide |
| GB0912909D0 (en) | 2009-07-23 | 2009-08-26 | Olink Genomics Ab | Probes for specific analysis of nucleic acids |
| US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| ES2645754T3 (es) | 2009-07-30 | 2017-12-07 | F. Hoffmann-La Roche Ag | Conjunto de sondas de oligonucleótidos así como métodos y usos relacionados con el mismo |
| SG178348A1 (en) | 2009-08-19 | 2012-03-29 | Merck Patent Gmbh | Antibodies for the detection of integrin complexes in ffpe material |
| CN102482668A (zh) | 2009-08-20 | 2012-05-30 | 群体遗传学科技有限公司 | 分子内核酸重排的组合物和方法 |
| US8476598B1 (en) | 2009-08-31 | 2013-07-02 | Sionyx, Inc. | Electromagnetic radiation imaging devices and associated methods |
| US20110082055A1 (en) | 2009-09-18 | 2011-04-07 | Codexis, Inc. | Reduced codon mutagenesis |
| US20120184724A1 (en) | 2009-09-22 | 2012-07-19 | Agilent Technologies, Inc. | Protected monomers and methods of deprotection for rna synthesis |
| WO2011038241A1 (en) | 2009-09-25 | 2011-03-31 | President And Fellows Of Harvard College | Nucleic acid amplification and sequencing by synthesis with fluorogenic nucleotides |
| US8975019B2 (en) | 2009-10-19 | 2015-03-10 | University Of Massachusetts | Deducing exon connectivity by RNA-templated DNA ligation/sequencing |
| US8389689B2 (en) | 2009-10-28 | 2013-03-05 | Janssen Biotech, Inc. | Anti-GLP-1R antibodies and their uses |
| WO2011053957A2 (en) | 2009-11-02 | 2011-05-05 | Gen9, Inc. | Compositions and methods for the regulation of multiple genes of interest in a cell |
| WO2011056872A2 (en) | 2009-11-03 | 2011-05-12 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| US20110114549A1 (en) | 2009-11-13 | 2011-05-19 | Agilent Technolgies, Inc. | Microfluidic device comprising separation columns |
| EP3085791A1 (en) | 2009-11-25 | 2016-10-26 | Gen9, Inc. | Methods and apparatuses for chip-based dna error reduction |
| WO2011066185A1 (en) | 2009-11-25 | 2011-06-03 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| US8500979B2 (en) | 2009-12-31 | 2013-08-06 | Intel Corporation | Nanogap chemical and biochemical sensors |
| US9217144B2 (en) | 2010-01-07 | 2015-12-22 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| US9758817B2 (en) | 2010-01-13 | 2017-09-12 | Agilent Technologies, Inc. | Method for identifying a nucleic acid in a sample |
| KR101230350B1 (ko) | 2010-01-27 | 2013-02-06 | 주식회사 엘지화학 | 구조적 안정성이 우수한 전지팩 |
| KR20110094878A (ko) | 2010-02-18 | 2011-08-24 | 삼성전자주식회사 | 올리고머 어레이 제조용 조성물 및 올리고머 어레이 제조 방법 |
| US20120027786A1 (en) | 2010-02-23 | 2012-02-02 | Massachusetts Institute Of Technology | Genetically programmable pathogen sense and destroy |
| GB201003036D0 (en) | 2010-02-23 | 2010-04-07 | Fermentas Uab | Restriction endonucleases and their applications |
| US8716467B2 (en) | 2010-03-03 | 2014-05-06 | Gen9, Inc. | Methods and devices for nucleic acid synthesis |
| CN102939380A (zh) | 2010-03-05 | 2013-02-20 | 合成基因组股份有限公司 | 用于克隆和操作基因组的方法 |
| WO2011143556A1 (en) | 2010-05-13 | 2011-11-17 | Gen9, Inc. | Methods for nucleotide sequencing and high fidelity polynucleotide synthesis |
| KR101339064B1 (ko) | 2010-05-28 | 2014-01-06 | 한양대학교 에리카산학협력단 | 바이오칩을 이용하여 암호를 해독하는 방법 및 이를 이용하여 바코드의 위조 여부를 확인하는 방법 |
| WO2011150168A1 (en) | 2010-05-28 | 2011-12-01 | Gen9, Inc. | Methods and devices for in situ nucleic acid synthesis |
| GB2481425A (en) | 2010-06-23 | 2011-12-28 | Iti Scotland Ltd | Method and device for assembling polynucleic acid sequences |
| DE102010027122A1 (de) | 2010-07-14 | 2012-01-19 | Airbus Operations Gmbh | Aufenthaltsmodul mit separatem Privatbereich |
| CA2805320A1 (en) | 2010-07-28 | 2012-02-02 | Immunocore Ltd | T cell receptors |
| ES2690753T3 (es) | 2010-09-21 | 2018-11-22 | Agilent Technologies, Inc. | Aumento de la confianza en las identificaciones de alelos con el recuento molecular |
| US8715933B2 (en) | 2010-09-27 | 2014-05-06 | Nabsys, Inc. | Assay methods using nicking endonucleases |
| WO2012045001A2 (en) | 2010-09-30 | 2012-04-05 | Vanderbilt University | Influenza virus antibodies and immunogens and uses therefor |
| WO2012051327A2 (en) | 2010-10-12 | 2012-04-19 | Cornell University | Method of dual-adapter recombination for efficient concatenation of multiple dna fragments in shuffled or specified arrangements |
| WO2012154201A1 (en) | 2010-10-22 | 2012-11-15 | President And Fellows Of Harvard College | Orthogonal amplification and assembly of nucleic acid sequences |
| CA2821299C (en) | 2010-11-05 | 2019-02-12 | Frank J. Steemers | Linking sequence reads using paired code tags |
| AU2011338841B2 (en) | 2010-11-12 | 2017-02-16 | Gen9, Inc. | Methods and devices for nucleic acids synthesis |
| EP2637780B1 (en) | 2010-11-12 | 2022-02-09 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| CN110079588B (zh) | 2010-12-17 | 2024-03-15 | 生命技术公司 | 用于核酸扩增的方法、组合物、系统、仪器和试剂盒 |
| WO2012092260A1 (en) | 2010-12-27 | 2012-07-05 | Ibis Biosciences, Inc. | Compositions and methods for producing single-stranded circular dna |
| US20120164633A1 (en) | 2010-12-27 | 2012-06-28 | Ibis Biosciences, Inc. | Digital droplet sequencing |
| CN103620032B (zh) | 2010-12-31 | 2016-02-24 | 生物蛋白有限公司 | 抗体的快速人源化 |
| SG194029A1 (en) | 2011-03-30 | 2013-11-29 | Nat Ct Geriatrics & Gerontology | Membrane-separation-type culture device, membrane-separation-type culture kit, stem cell separation method using same, and separation membrane |
| US10131903B2 (en) | 2011-04-01 | 2018-11-20 | The Regents Of The University Of California | Microfluidic platform for synthetic biology applications |
| US9384920B1 (en) | 2011-04-04 | 2016-07-05 | Eric J. Bakulich | Locking knob |
| WO2012149171A1 (en) | 2011-04-27 | 2012-11-01 | The Regents Of The University Of California | Designing padlock probes for targeted genomic sequencing |
| US8722585B2 (en) | 2011-05-08 | 2014-05-13 | Yan Wang | Methods of making di-tagged DNA libraries from DNA or RNA using double-tagged oligonucleotides |
| SG194745A1 (en) | 2011-05-20 | 2013-12-30 | Fluidigm Corp | Nucleic acid encoding reactions |
| US9752176B2 (en) | 2011-06-15 | 2017-09-05 | Ginkgo Bioworks, Inc. | Methods for preparative in vitro cloning |
| ES2662372T3 (es) | 2011-06-21 | 2018-04-06 | Vib Vzw | Dominios de unión dirigidos contra complejos GPCR:proteína G y usos derivados de los mismos |
| CA2840542A1 (en) | 2011-06-28 | 2013-01-03 | Igor Kutyavin | Methods and compositions for enrichment of nucleic acids in mixtures of highly homologous sequences |
| US20130045483A1 (en) | 2011-07-01 | 2013-02-21 | Whitehead Institute For Biomedical Research | Yeast cells expressing amyloid beta and uses therefor |
| US9139874B2 (en) | 2011-07-07 | 2015-09-22 | Life Technologies Corporation | Bi-directional sequencing compositions and methods |
| US20130017978A1 (en) | 2011-07-11 | 2013-01-17 | Finnzymes Oy | Methods and transposon nucleic acids for generating a dna library |
| WO2013010062A2 (en) | 2011-07-14 | 2013-01-17 | Life Technologies Corporation | Nucleic acid complexity reduction |
| AU2012300401B2 (en) | 2011-08-26 | 2018-02-08 | Ginkgo Bioworks, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
| US20150203839A1 (en) | 2011-08-26 | 2015-07-23 | Gen9, Inc. | Compositions and Methods for High Fidelity Assembly of Nucleic Acids |
| US20150120265A1 (en) | 2011-09-01 | 2015-04-30 | Genome Compiler Corporation | System for polynucleotide construct design, visualization and transactions to manufacture the same |
| US10752944B2 (en) | 2011-09-06 | 2020-08-25 | Gen-Probe Incorporated | Circularized templates for sequencing |
| US8840981B2 (en) | 2011-09-09 | 2014-09-23 | Eastman Kodak Company | Microfluidic device with multilayer coating |
| US20130109596A1 (en) | 2011-09-26 | 2013-05-02 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| US20130091126A1 (en) | 2011-10-11 | 2013-04-11 | Life Technologies Corporation | Systems and methods for analysis and interpretation of nucleic acid sequence data |
| EP2769007B1 (en) | 2011-10-19 | 2016-12-07 | Nugen Technologies, Inc. | Compositions and methods for directional nucleic acid amplification and sequencing |
| US8987174B2 (en) | 2011-10-28 | 2015-03-24 | Prognosys Biosciences, Inc. | Methods for manufacturing molecular arrays |
| US8815782B2 (en) | 2011-11-11 | 2014-08-26 | Agilent Technologies, Inc. | Use of DNAzymes for analysis of an RNA sample |
| US20130137173A1 (en) | 2011-11-30 | 2013-05-30 | Feng Zhang | Nucleotide-specific recognition sequences for designer tal effectors |
| US8450107B1 (en) | 2011-11-30 | 2013-05-28 | The Broad Institute Inc. | Nucleotide-specific recognition sequences for designer TAL effectors |
| JP2013151468A (ja) | 2011-11-30 | 2013-08-08 | Agilent Technologies Inc | オリゴマーの合成及び精製の新規方法 |
| US9279154B2 (en) | 2011-12-21 | 2016-03-08 | Illumina, Inc. | Apparatus and methods for kinetic analysis and determination of nucleic acid sequences |
| WO2013093693A1 (en) | 2011-12-22 | 2013-06-27 | Rinat Neuroscience Corp. | Staphylococcus aureus specific antibodies and uses thereof |
| WO2013101896A1 (en) | 2011-12-30 | 2013-07-04 | Quest Diagnostics Investments Incorporated | Nucleic acid analysis using emulsion pcr |
| WO2013101783A2 (en) | 2011-12-30 | 2013-07-04 | Bio-Rad Laboratories, Inc. | Methods and compositions for performing nucleic acid amplification reactions |
| EP2809795B1 (en) | 2012-02-01 | 2019-09-18 | SGI-DNA, Inc. | Materials and methods for the synthesis of error-minimized nucleic acid molecules |
| US11177020B2 (en) | 2012-02-27 | 2021-11-16 | The University Of North Carolina At Chapel Hill | Methods and uses for molecular tags |
| WO2013128281A1 (en) | 2012-02-28 | 2013-09-06 | Population Genetics Technologies Ltd | Method for attaching a counter sequence to a nucleic acid sample |
| WO2013134881A1 (en) | 2012-03-14 | 2013-09-19 | Innovative Targeting Solutions Inc. | Generating targeted sequence diversity in fusion proteins |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| EP2830555B1 (en) | 2012-03-28 | 2017-08-02 | KCI Licensing, Inc. | Reduced-pressure systems and dressings facilitating separation of electronic and clinical component parts |
| US9732384B2 (en) | 2012-04-02 | 2017-08-15 | Lux Bio Group, Inc. | Apparatus and method for molecular separation, purification, and sensing |
| RU2014144947A (ru) | 2012-04-10 | 2016-05-27 | Те Трастиз Оф Принстон Юниверсити | Ультрачувствительный сенсор |
| US20150353921A9 (en) | 2012-04-16 | 2015-12-10 | Jingdong Tian | Method of on-chip nucleic acid molecule synthesis |
| US20130281308A1 (en) | 2012-04-24 | 2013-10-24 | Gen9, Inc. | Methods for sorting nucleic acids and preparative in vitro cloning |
| EP2841601B1 (en) | 2012-04-24 | 2019-03-06 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| AU2013259276B2 (en) * | 2012-05-10 | 2018-03-22 | Bioatla Llc | Multi-specific monoclonal antibodies |
| WO2013177220A1 (en) | 2012-05-21 | 2013-11-28 | The Scripps Research Institute | Methods of sample preparation |
| ES3028417T3 (en) | 2012-06-01 | 2025-06-19 | European Molecular Biology Laboratory | High-capacity storage of digital information in dna |
| US10308979B2 (en) | 2012-06-01 | 2019-06-04 | Agilent Technologies, Inc. | Target enrichment and labeling for multi-kilobase DNA |
| WO2013188037A2 (en) | 2012-06-11 | 2013-12-19 | Agilent Technologies, Inc | Method of adaptor-dimer subtraction using a crispr cas6 protein |
| CN104350161A (zh) | 2012-06-14 | 2015-02-11 | 弗莱德哈钦森癌症研究中心 | 用于核酸分子中的敏感突变检测的组合物和方法 |
| US20150191719A1 (en) | 2012-06-25 | 2015-07-09 | Gen9, Inc. | Methods for Nucleic Acid Assembly and High Throughput Sequencing |
| US9255245B2 (en) | 2012-07-03 | 2016-02-09 | Agilent Technologies, Inc. | Sample probes and methods for sampling intracellular material |
| SG10201610861XA (en) | 2012-07-03 | 2017-02-27 | Integrated Dna Tech Inc | Tm-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection |
| WO2014011800A1 (en) | 2012-07-10 | 2014-01-16 | Pivot Bio, Inc. | Methods for multipart, modular and scarless assembly of dna molecules |
| WO2014012071A1 (en) | 2012-07-12 | 2014-01-16 | Massachusetts Institute Of Technology | Methods and apparatus for assembly |
| JP6239813B2 (ja) | 2012-07-18 | 2017-11-29 | 株式会社Screenセミコンダクターソリューションズ | 基板処理装置および基板処理方法 |
| CA2878042C (en) | 2012-07-19 | 2017-11-28 | President And Fellows Of Harvard College | Methods of storing information using nucleic acids |
| WO2014018863A1 (en) | 2012-07-27 | 2014-01-30 | The Board Of Trustees Of The University Of Illinois | Engineering t-cell receptors |
| WO2014021938A1 (en) | 2012-08-02 | 2014-02-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and apparatus for nucleic acid synthesis using oligo-templated polymerization |
| SG10201701022VA (en) | 2012-08-16 | 2017-04-27 | Synthetic Genomics Inc | Digital to biological converter |
| JP6590694B2 (ja) * | 2012-08-31 | 2019-10-16 | ザ スクリプス リサーチ インスティテュート | 真核生物細胞の調節因子に関する方法及び組成物 |
| WO2014039587A1 (en) | 2012-09-05 | 2014-03-13 | Bio-Rad Laboratories, Inc. | Systems and methods for stabilizing droplets |
| WO2014062717A1 (en) | 2012-10-15 | 2014-04-24 | Life Technologies Corporation | Compositions, methods, systems and kits for target nucleic acid enrichment |
| KR20140048733A (ko) | 2012-10-16 | 2014-04-24 | 삼성전자주식회사 | 다중 웰 플레이트 및 상기 다중 웰 플레이트를 이용한 표적 물질 분석 방법 |
| EP2912197B1 (en) | 2012-10-24 | 2019-08-07 | Takara Bio USA, Inc. | Template switch-based methods for producing a product nucleic acid |
| CA2932532C (en) | 2012-12-04 | 2021-06-22 | Phosphorex, Inc. | Microparticles and nanoparticles having negative surface charges |
| US10072260B2 (en) | 2012-12-06 | 2018-09-11 | Agilent Technologies, Inc. | Target enrichment of randomly sheared genomic DNA fragments |
| US10662424B2 (en) | 2012-12-06 | 2020-05-26 | Agilent Technologies, Inc. | Molecular fabrication |
| EP3561072A1 (en) | 2012-12-10 | 2019-10-30 | Resolution Bioscience, Inc. | Methods for targeted genomic analysis |
| US9976162B2 (en) | 2012-12-10 | 2018-05-22 | Agilent Technologies, Inc. | Pairing code directed assembly |
| US20140310830A1 (en) | 2012-12-12 | 2014-10-16 | Feng Zhang | CRISPR-Cas Nickase Systems, Methods And Compositions For Sequence Manipulation in Eukaryotes |
| EP2962110A4 (en) | 2013-02-28 | 2016-11-02 | Univ Nanyang Tech | METHOD FOR PRODUCING A DEVICE SUPPORTING THE GROWTH OF BIOLOGICAL MATERIAL AND DEVICE THEREOF |
| US9580746B2 (en) | 2013-03-05 | 2017-02-28 | Agilent Technologies, Inc. | Synthesis of long fish probes |
| EP2964778B1 (en) | 2013-03-05 | 2019-10-09 | Agilent Technologies, Inc. | Detection of genomic rearrangements by sequence capture |
| EP3828277B1 (en) | 2013-03-13 | 2023-06-07 | Gen9, Inc. | Compositions, methods and apparatus for oligonucleotides synthesis |
| WO2014160059A1 (en) | 2013-03-13 | 2014-10-02 | Gen9, Inc. | Compositions and methods for synthesis of high fidelity oligonucleotides |
| US20140274729A1 (en) | 2013-03-15 | 2014-09-18 | Nugen Technologies, Inc. | Methods, compositions and kits for generation of stranded rna or dna libraries |
| CA2906556C (en) | 2013-03-15 | 2022-07-05 | Gen9, Inc. | Compositions and methods for multiplex nucleic acids synthesis |
| MX2015012326A (es) | 2013-03-15 | 2016-03-08 | Genentech Inc | Anticuerpos anti-crth2 y su uso. |
| EP4253558B1 (en) | 2013-03-15 | 2025-07-02 | The Board of Trustees of the Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| US20140274741A1 (en) | 2013-03-15 | 2014-09-18 | The Translational Genomics Research Institute | Methods to capture and sequence large fragments of dna and diagnostic methods for neuromuscular disease |
| US9771613B2 (en) | 2013-04-02 | 2017-09-26 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acid |
| US9279149B2 (en) | 2013-04-02 | 2016-03-08 | Molecular Assemblies, Inc. | Methods and apparatus for synthesizing nucleic acids |
| US10683536B2 (en) | 2013-04-02 | 2020-06-16 | Molecular Assemblies, Inc. | Reusable initiators for synthesizing nucleic acids |
| US20150293102A1 (en) | 2013-04-13 | 2015-10-15 | Jung-Uk Shim | Detecting low-abundant analyte in microfluidic droplets |
| ITRM20130278A1 (it) | 2013-05-10 | 2014-11-11 | Consiglio Nazionale Ricerche | Procedimento di fabbricazione di film autoassemblati di copolimeri a blocchi |
| RU2645256C2 (ru) | 2013-06-26 | 2018-02-19 | Гуандун Сянсюэ Лайф Сайенсис, Лтд. | Высокостабильный т-клеточный рецептор и способ его получения и применения |
| US20150010953A1 (en) | 2013-07-03 | 2015-01-08 | Agilent Technologies, Inc. | Method for producing a population of oligonucleotides that has reduced synthesis errors |
| KR20150005062A (ko) | 2013-07-04 | 2015-01-14 | 삼성전자주식회사 | 미니-코어를 사용하는 프로세서 |
| US10421957B2 (en) | 2013-07-29 | 2019-09-24 | Agilent Technologies, Inc. | DNA assembly using an RNA-programmable nickase |
| LT3027771T (lt) | 2013-07-30 | 2019-04-25 | Gen9, Inc. | Ilgos kloninės sekos verifikuotų nukleorūgščių konstruktų gamybos būdas |
| US9409139B2 (en) | 2013-08-05 | 2016-08-09 | Twist Bioscience Corporation | De novo synthesized gene libraries |
| US9589445B2 (en) | 2013-08-07 | 2017-03-07 | Nike, Inc. | Activity recognition with activity reminders |
| CN104371019B (zh) | 2013-08-13 | 2019-09-10 | 鸿运华宁(杭州)生物医药有限公司 | 一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质 |
| GB201314721D0 (en) | 2013-08-16 | 2013-10-02 | Almagen Ltd | A method of selectively masking one or more sites on a surface and a method of synthesising an array of molecules |
| EP4567682A3 (en) | 2013-08-30 | 2025-09-03 | Personalis, Inc. | Methods for genomic analysis |
| WO2015039053A2 (en) | 2013-09-14 | 2015-03-19 | Chemgenes Corporation | Highly efficient synthesis of long rna using reverse direction approach |
| WO2015040075A1 (en) | 2013-09-18 | 2015-03-26 | Genome Research Limited | Genomic screening methods using rna-guided endonucleases |
| US9422325B2 (en) | 2013-10-04 | 2016-08-23 | Trustees Of Tufts College | Glycosylation reactions using phenyl(trifluoroethyl)iodonium salts |
| JP2017504307A (ja) | 2013-10-07 | 2017-02-09 | セルラー リサーチ, インコーポレイテッド | アレイ上のフィーチャーをデジタルカウントするための方法およびシステム |
| CA2929108A1 (en) | 2013-10-29 | 2015-05-07 | Longhorn Vaccines And Diagnostics, Llc | Next generation genomic sequencing methods |
| EP3073967A1 (en) | 2013-11-26 | 2016-10-05 | Xenco Medical, LLC | Lock and release implant delivery system |
| US20170175110A1 (en) * | 2013-11-27 | 2017-06-22 | Gen9, Inc. | Libraries of Nucleic Acids and Methods for Making the Same |
| US20160297883A1 (en) | 2013-12-04 | 2016-10-13 | Innovative Targeting Solutions, Inc. | G-protein coupled receptor agonists and methods |
| TW202446953A (zh) | 2013-12-04 | 2024-12-01 | 日商中外製藥股份有限公司 | 因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫 |
| AU2014363967A1 (en) | 2013-12-09 | 2017-01-05 | Shawn Allen | Long nucleic acid sequences containing variable regions |
| KR102630750B1 (ko) | 2013-12-17 | 2024-01-30 | 제넨테크, 인크. | Pd-1 축 결합 길항제 및 탁산을 이용한 암 치료 방법 |
| GB2521387B (en) | 2013-12-18 | 2020-05-27 | Ge Healthcare Uk Ltd | Oligonucleotide data storage on solid supports |
| US10537889B2 (en) | 2013-12-31 | 2020-01-21 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
| US9587268B2 (en) | 2014-01-29 | 2017-03-07 | Agilent Technologies Inc. | Fast hybridization for next generation sequencing target enrichment |
| US10287627B2 (en) | 2014-02-08 | 2019-05-14 | The Regents Of The University Of Colorado, A Body Corporate | Multiplexed linking PCR |
| EP3114231B1 (en) | 2014-03-03 | 2019-01-02 | Swift Biosciences, Inc. | Enhanced adaptor ligation |
| BR112016021004A2 (pt) | 2014-03-14 | 2018-01-23 | Immunocore Limited | biblioteca de partículas; receptor de células t (tcr) isolado não natural; uso de uma biblioteca; método de obtenção de um receptor de células t que se liga especificamente a um antígeno de peptídeo; ácido nucleico; método de construção de uma biblioteca de partículas; método de obtenção de um receptor de células t que se liga especificamente a um antígeno de peptídeo; e partícula |
| US10675618B2 (en) | 2014-03-27 | 2020-06-09 | University Of Maryland, College Park | Integration of ex situ fabricated porous polymer monoliths into fluidic chips |
| US10190161B2 (en) | 2014-04-03 | 2019-01-29 | Stmicroelectronics S.R.L. | Apparatus and method for nucleic acid sequencing based on nanowire detectors |
| WO2015160004A1 (ko) | 2014-04-15 | 2015-10-22 | 볼보 컨스트럭션 이큅먼트 에이비 | 건설기계의 엔진, 유압펌프의 제어장치 및 그 제어방법 |
| GB201407852D0 (en) | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| EP3143161B1 (en) | 2014-05-16 | 2021-04-21 | Illumina, Inc. | Nucleic acid synthesis techniques |
| US20150361422A1 (en) | 2014-06-16 | 2015-12-17 | Agilent Technologies, Inc. | High throughput gene assembly in droplets |
| US20150361423A1 (en) | 2014-06-16 | 2015-12-17 | Agilent Technologies, Inc. | High throughput gene assembly in droplets |
| US10472620B2 (en) | 2014-07-01 | 2019-11-12 | General Electric Company | Method, substrate and device for separating nucleic acids |
| US10870845B2 (en) | 2014-07-01 | 2020-12-22 | Global Life Sciences Solutions Operations UK Ltd | Methods for capturing nucleic acids |
| EP3167071B1 (en) | 2014-07-09 | 2020-10-07 | Gen9, Inc. | Compositions and methods for site-directed dna nicking and cleaving |
| US11254933B2 (en) | 2014-07-14 | 2022-02-22 | The Regents Of The University Of California | CRISPR/Cas transcriptional modulation |
| US20160017394A1 (en) | 2014-07-15 | 2016-01-21 | Life Technologies Corporation | Compositions and methods for nucleic acid assembly |
| WO2016022557A1 (en) | 2014-08-05 | 2016-02-11 | Twist Bioscience Corporation | Cell free cloning of nucleic acids |
| EP3913066A1 (en) | 2014-09-09 | 2021-11-24 | Igenomx International Genomics Corporation | Compositions for rapid nucleic acid library preparation |
| US20170247756A1 (en) | 2014-10-03 | 2017-08-31 | Life Technologies Corporation | Genetic sequence verification compositions, methods and kits |
| EP3204513A2 (en) | 2014-10-09 | 2017-08-16 | Life Technologies Corporation | Crispr oligonucleotides and gene editing |
| WO2016055956A1 (en) | 2014-10-10 | 2016-04-14 | Invitae Corporation | Universal blocking oligo system and improved hybridization capture methods for multiplexed capture reactions |
| WO2016059610A1 (en) | 2014-10-18 | 2016-04-21 | Malik Girik | A biomolecule based data storage system |
| US10434507B2 (en) | 2014-10-22 | 2019-10-08 | The Regents Of The University Of California | High definition microdroplet printer |
| US9890417B2 (en) | 2014-11-03 | 2018-02-13 | Agilent Technologies, Inc. | Signal amplification of fluorescence in situ hybridization |
| US10233490B2 (en) | 2014-11-21 | 2019-03-19 | Metabiotech Corporation | Methods for assembling and reading nucleic acid sequences from mixed populations |
| CN104562213A (zh) | 2014-12-26 | 2015-04-29 | 北京诺禾致源生物信息科技有限公司 | 扩增子文库及其构建方法 |
| CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| CA3253836A1 (en) | 2015-02-04 | 2025-12-01 | Twist Bioscience Corp | Compositions and methods for synthetic gene assembly |
| US9834774B2 (en) | 2015-02-11 | 2017-12-05 | Agilent Technologies, Inc. | Methods and compositions for rapid seamless DNA assembly |
| US10253363B2 (en) | 2015-02-13 | 2019-04-09 | Vaccine Research Institute Of San Diego | Materials and methods to analyze RNA isoforms in transcriptomes |
| CN104734848A (zh) | 2015-03-02 | 2015-06-24 | 郑州轻工业学院 | 基于重组dna技术对信息进行加密与隐藏的方法及应用 |
| CN107847543A (zh) | 2015-04-01 | 2018-03-27 | 斯克利普斯研究院 | 与gpcr激动剂多肽相关的方法和组合物 |
| US10730911B2 (en) | 2015-04-08 | 2020-08-04 | Universitat Zurich | Backbone-cyclized peptidomimetics with GLP-1R modulating activity |
| WO2016164779A1 (en) | 2015-04-10 | 2016-10-13 | University Of Washington | Integrated system for nucleic acid-based storage of digital data |
| EP3283512A4 (en) | 2015-04-17 | 2018-10-03 | Distributed Bio Inc | Method for mass humanization of non-human antibodies |
| WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| CA2988001C (en) | 2015-04-30 | 2023-09-26 | Abcheck S.R.O. | Method for mass humanization of rabbit antibodies |
| WO2016183100A1 (en) | 2015-05-11 | 2016-11-17 | Twist Bioscience Corporation | Compositions and methods for nucleic acid amplification |
| JP6920275B2 (ja) | 2015-07-13 | 2021-08-18 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 核酸を用いた回収可能な情報記憶のための方法 |
| AU2016324296A1 (en) | 2015-09-18 | 2018-04-12 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| WO2017059399A1 (en) | 2015-10-01 | 2017-04-06 | University Of Washington | Multiplex pairwise assembly of dna oligonucleotides |
| US20170141793A1 (en) | 2015-11-13 | 2017-05-18 | Microsoft Technology Licensing, Llc | Error correction for nucleotide data stores |
| CN108603307A (zh) | 2015-12-01 | 2018-09-28 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
| WO2017100441A1 (en) | 2015-12-08 | 2017-06-15 | Twinstrand Biosciences, Inc. | Improved adapters, methods, and compositions for duplex sequencing |
| EP3786292A1 (en) | 2016-01-08 | 2021-03-03 | Maxion Therapeutics Limited | Binding members with altered diversity scaffold domains |
| GB201604492D0 (en) | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Transfected t-cells and t-cell receptors for use in immunotherapy against cancers |
| WO2017214557A1 (en) | 2016-06-10 | 2017-12-14 | Counsyl, Inc. | Nucleic acid sequencing adapters and uses thereof |
| CN109564769A (zh) | 2016-06-10 | 2019-04-02 | 特韦斯特生物科学公司 | 用于自动注释和筛选生物序列的系统和方法 |
| CN110088281A (zh) | 2016-08-03 | 2019-08-02 | 特韦斯特生物科学公司 | 用于多核苷酸合成的纹理化表面 |
| CA3034769A1 (en) | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
| CN117298260A (zh) | 2016-09-02 | 2023-12-29 | 莱蒂恩技术公司 | 用DuoCAR治疗癌症的组合物和方法 |
| CN110248724B (zh) | 2016-09-21 | 2022-11-18 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| KR102569164B1 (ko) | 2016-11-18 | 2023-08-21 | 트위스트 바이오사이언스 코포레이션 | 조절된 화학량론을 갖는 폴리뉴클레오티드 라이브러리 및 이의 합성 |
| CN110366613A (zh) | 2016-12-16 | 2019-10-22 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| SI3558369T1 (sl) | 2016-12-21 | 2025-06-30 | Cephalon Llc | Protitelesa, ki se specifično vežejo na človeški il-15, in njihova uporaba |
| WO2018156792A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
| AU2018234624B2 (en) | 2017-03-15 | 2023-11-16 | Twist Bioscience Corporation | De novo synthesized combinatorial nucleic acid libraries |
| CN110913865A (zh) | 2017-03-15 | 2020-03-24 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| ES2953575T3 (es) | 2017-03-23 | 2023-11-14 | QBiotics Pty Ltd | Terapia de combinación para el tratamiento o la prevención de tumores |
| WO2018183918A1 (en) | 2017-03-30 | 2018-10-04 | Grail, Inc. | Enhanced ligation in sequencing library preparation |
| US10995369B2 (en) | 2017-04-23 | 2021-05-04 | Illumina, Inc. | Compositions and methods for improving sample identification in indexed nucleic acid libraries |
| CN120060440A (zh) | 2017-05-08 | 2025-05-30 | 伊鲁米那股份有限公司 | 用于多核苷酸样品的索引的通用短衔接子 |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for assembling continuous nucleic acids |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| EP3656461A4 (en) | 2017-07-18 | 2021-03-03 | Investigaciones Forestales Bioforest S.A. | METHOD AND DEVICE FOR ASYMMETRIC POLARITY REVERSAL IN ELECTROMEMBRANE PROCESSES |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| KR102637566B1 (ko) | 2017-10-20 | 2024-02-16 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| WO2019084500A1 (en) | 2017-10-27 | 2019-05-02 | Twist Bioscience Corporation | SYSTEMS AND METHODS FOR CLASSIFYING POLYNUCLEOTIDES |
| US11427867B2 (en) | 2017-11-29 | 2022-08-30 | Xgenomes Corp. | Sequencing by emergence |
| CN112041438B (zh) | 2018-01-04 | 2025-05-23 | 特韦斯特生物科学公司 | 基于dna的数字信息存储 |
| US10722916B2 (en) | 2018-01-19 | 2020-07-28 | Caulk Garbage Can LLC | Caulk gun attachment for wiping excess caulk |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| WO2020001783A1 (en) | 2018-06-29 | 2020-01-02 | Thermo Fisher Scientific Geneart Gmbh | High throughput assembly of nucleic acid molecules |
| US10963953B2 (en) | 2018-10-10 | 2021-03-30 | Alliance Inspection Management, LLC | Reserve management for continuous bidding portal |
| US10969965B2 (en) | 2018-12-24 | 2021-04-06 | Western Digital Technologies, Inc. | Dynamic performance density tuning for data storage device |
| CA3124980A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| US20210002710A1 (en) | 2019-02-25 | 2021-01-07 | Twist Bioscience Corporation | Compositions and methods for next generation sequencing |
| CN113785057A (zh) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | 用于抗体优化的变异核酸文库 |
| KR20210143766A (ko) | 2019-02-26 | 2021-11-29 | 트위스트 바이오사이언스 코포레이션 | Glp1 수용체에 대한 변이체 핵산 라이브러리 |
| JP2022550497A (ja) | 2019-06-21 | 2022-12-02 | ツイスト バイオサイエンス コーポレーション | バーコードに基づいた核酸配列アセンブリ |
| US20220243195A1 (en) | 2019-06-21 | 2022-08-04 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| US20220259638A1 (en) | 2019-07-22 | 2022-08-18 | Igenomx International Genomics Corporation | Methods and compositions for high throughput sample preparation using double unique dual indexing |
| EP4028586A4 (en) | 2019-09-13 | 2023-10-04 | University Health Network | Detection of circulating tumor dna using double stranded hybrid capture |
| AU2020355027A1 (en) | 2019-09-23 | 2022-04-21 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| CA3155629A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for crth2 |
| CN115066518A (zh) | 2019-12-09 | 2022-09-16 | 特韦斯特生物科学公司 | 针对腺苷受体的变体核酸文库 |
| CA3177029A1 (en) | 2020-04-27 | 2021-11-04 | Aaron Sato | Variant nucleic acid libraries for coronavirus |
| AU2021303409A1 (en) | 2020-07-07 | 2023-02-16 | Twist Bioscience Corporation | Devices and methods for light-directed polymer synthesis |
| WO2022046797A1 (en) | 2020-08-25 | 2022-03-03 | Twist Bioscience Corporation | Compositions and methods for library sequencing |
| US12391762B2 (en) | 2020-08-26 | 2025-08-19 | Twist Bioscience Corporation | Methods and compositions relating to GLP1R variants |
| WO2022047076A1 (en) | 2020-08-28 | 2022-03-03 | Twist Bioscience Corporation | Devices and methods for synthesis |
| EP4225912A1 (en) | 2020-10-05 | 2023-08-16 | Twist Bioscience Corporation | Hybridization methods and reagents |
| US11970697B2 (en) | 2020-10-19 | 2024-04-30 | Twist Bioscience Corporation | Methods of synthesizing oligonucleotides using tethered nucleotides |
| US20220206001A1 (en) | 2020-10-22 | 2022-06-30 | Twist Bioscience Corporation | Methods and systems for detecting coronavirus |
| US20220135965A1 (en) | 2020-10-26 | 2022-05-05 | Twist Bioscience Corporation | Libraries for next generation sequencing |
| WO2022098662A2 (en) | 2020-11-03 | 2022-05-12 | Twist Bioscience Corporation | Methods and compositions relating to chemokine receptor variants |
| EP4281112A4 (en) | 2021-01-21 | 2025-01-15 | Twist Bioscience Corporation | METHODS AND COMPOSITIONS RELATING TO ADENOSINE RECEPTORS |
| WO2022178137A1 (en) | 2021-02-19 | 2022-08-25 | Twist Bioscience Corporation | Libraries for identification of genomic variants |
| US12258406B2 (en) | 2021-03-24 | 2025-03-25 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| WO2022204309A1 (en) | 2021-03-24 | 2022-09-29 | Twist Bioscience Corporation | Variant nucleic acid libraries for tigit |
| US20220323924A1 (en) | 2021-03-24 | 2022-10-13 | Twist Bioscience Corporation | Electrochemical polynucleotide synthesis |
| US20220356463A1 (en) | 2021-04-09 | 2022-11-10 | Twist Bioscience Corporation | Libraries for mutational analysis |
| EP4334515A1 (en) | 2021-05-03 | 2024-03-13 | Twist Bioscience Corporation | Variant nucleic acid libraries for glycans |
| US20220356468A1 (en) | 2021-05-03 | 2022-11-10 | Twist Bioscience Corporation | Variant nucleic acid libraries for ion channels |
| WO2022271884A2 (en) | 2021-06-22 | 2022-12-29 | Twist Bioscience Corporation | Methods and compositions relating to covid antibody epitopes |
| US20230192819A1 (en) | 2021-08-17 | 2023-06-22 | Twist Bioscience Corporation | Single domain antibodies for sars-cov-2 |
| WO2023023183A2 (en) | 2021-08-17 | 2023-02-23 | Twist Bioscience Corporation | Sars-cov-2 antibodies and related compositions and methods of use |
| WO2023023285A2 (en) | 2021-08-19 | 2023-02-23 | Twist Bioscience Corporation | Methods and compositions relating to covalently closed nucleic acids |
-
2016
- 2016-09-16 AU AU2016324296A patent/AU2016324296A1/en not_active Abandoned
- 2016-09-16 IL IL258164A patent/IL258164B/en unknown
- 2016-09-16 GB GB1804999.9A patent/GB2557529A/en not_active Withdrawn
- 2016-09-16 KR KR1020187010998A patent/KR20180050411A/ko not_active Ceased
- 2016-09-16 JP JP2018512262A patent/JP6982362B2/ja active Active
- 2016-09-16 WO PCT/US2016/052336 patent/WO2017049231A1/en not_active Ceased
- 2016-09-16 EP EP16847497.1A patent/EP3350314A4/en not_active Withdrawn
- 2016-09-16 US US15/268,422 patent/US10844373B2/en active Active
- 2016-09-16 HK HK19101342.2A patent/HK1258869A1/zh unknown
- 2016-09-16 CA CA2998169A patent/CA2998169A1/en active Pending
- 2016-09-16 CN CN201680067225.6A patent/CN108368482A/zh active Pending
- 2016-09-16 EA EA201890763A patent/EA201890763A1/ru unknown
-
2020
- 2020-10-12 US US17/068,551 patent/US11807956B2/en active Active
-
2022
- 2022-11-29 AU AU2022279404A patent/AU2022279404A1/en not_active Abandoned
-
2023
- 2023-07-21 US US18/356,787 patent/US20240158955A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EA201890763A1 (ru) | 2018-08-31 |
| EP3350314A1 (en) | 2018-07-25 |
| IL258164B (en) | 2022-09-01 |
| US20210040476A1 (en) | 2021-02-11 |
| WO2017049231A1 (en) | 2017-03-23 |
| AU2016324296A1 (en) | 2018-04-12 |
| US20240158955A1 (en) | 2024-05-16 |
| CN108368482A (zh) | 2018-08-03 |
| IL258164A (en) | 2018-05-31 |
| JP6982362B2 (ja) | 2021-12-17 |
| CA2998169A1 (en) | 2017-03-23 |
| GB201804999D0 (en) | 2018-05-09 |
| HK1258869A1 (zh) | 2019-11-22 |
| US10844373B2 (en) | 2020-11-24 |
| GB2557529A (en) | 2018-06-20 |
| EP3350314A4 (en) | 2019-02-06 |
| JP2018532705A (ja) | 2018-11-08 |
| AU2022279404A1 (en) | 2023-03-02 |
| US11807956B2 (en) | 2023-11-07 |
| US20170081660A1 (en) | 2017-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240158955A1 (en) | Oligonucleic acid variant libraries and synthesis thereof | |
| JP7696937B2 (ja) | デノボ合成されたコンビナトリアル核酸ライブラリー | |
| US10894959B2 (en) | Variant libraries of the immunological synapse and synthesis thereof | |
| KR102514213B1 (ko) | 면역 시냅스의 변이체 라이브러리 및 그의 합성 | |
| KR20220069046A (ko) | 단일 도메인 항체에 대한 변이체 핵산 라이브러리 | |
| US20230340461A1 (en) | Combinatorial dna assembly for multispecific antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20180418 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20210915 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230630 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20231018 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20230630 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |